<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Renal System - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / qBank / Pathology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">62</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 14946,
    "choices": [
      {
        "id": 59744,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lupus nephritis </span></span></span></p>"
      },
      {
        "id": 59745,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangiocapillary glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 59746,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diarrhea-associated hemolytic uremic syndrome </span></span></span></p>"
      },
      {
        "id": 59747,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-infections glomerulonephritis </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are associated with low complement levels except: </span></span></span></p>",
    "unique_key": "Q9265854",
    "question_audio": null,
    "question_video": null,
    "map_id": 32109,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Diarrhea associated hemolytic uremic syn&shy;drome </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diarrhea-associated Hemolytic Uremic Syndrome (HUS):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Typically, in diarrhea-associated HUS, which is often caused by infection with <strong>Shiga toxin-producing E. coli,</strong> <strong>complement levels </strong>are <strong>not</strong> affected. This condition <strong>does not </strong>usually involve<strong> immune complex deposition or complement activation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Lupus Nephritis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In lupus nephritis, an <strong>autoimmune </strong>condition where the <strong>body&#39;s own immune system </strong>attacks the<strong> kidneys</strong>, <strong>low complement levels </strong>are common due to the <strong>consumption of complement </strong>in the formation of <strong>immune complexes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Mesangiocapillary Glomerulonephritis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition, also known as <strong>membranoproliferative glomerulonephritis, </strong>involves the deposition of<strong> immune complexes </strong>in the <strong>mesangium and capillary walls of the kidneys</strong>, often leading to persistent<strong> low complement levels</strong>, particularly<strong> C3</strong>, due to the <strong>activation of the complement system</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Post-infectious Glomerulonephritis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This usually occurs after infections such as <strong>streptococcal infection</strong>. While it can result in<strong> transient low complement levels </strong>due to<strong> immune complex deposition </strong>and <strong>complement activation</strong>, the levels usually return to <strong>normal within several weeks</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low complement levels </strong>are typically associated with conditions involving<strong> immune complex deposition </strong>and <strong>activation </strong>of the <strong>complement pathway</strong>, such as<strong> lupus nephritis, mesangiocapillary glomerulonephritis, and post-infectious glomerulonephritis.</strong> <strong>Diarrhea-associated hemolytic uremic syndrome</strong>, however,<strong> does not </strong>commonly involve <strong>complement system </strong>alterations, setting it apart from other causes of <strong>nephritic syndrome with low complement levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nephritic syndrome associated with low C3 </span></span></strong></span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/16/picture4_4LkejF5.jpg\" style=\"height:261px; width:1000px\" /></span></span></strong></span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref:&nbsp; 10<sup>th</sup>/ 938) </span></em></strong></span></span></p>",
    "correct_choice_id": 59746,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14947,
    "choices": [
      {
        "id": 59748,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post streptococcal glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 59749,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Membranoproliferative glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 59750,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Goodpasture&rsquo;s disease </span></span></span></p>"
      },
      {
        "id": 59751,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Systemic lupus erythematosus</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are associated with low C3 level except:<em> </em></span></span></span></p>",
    "unique_key": "Q6971915",
    "question_audio": null,
    "question_video": null,
    "map_id": 32110,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Goodpasture&rsquo;s disease </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Goodpasture&rsquo;s disease:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is an <strong>autoimmune disease</strong> where <strong>antibodies target the basement membrane in the lungs and kidneys</strong>. Typically, it is <strong>not associated with low serum C3 levels</strong> because the pathophysiology <strong>does not </strong>involve the <strong>classical complement</strong> <strong>pathway activation</strong> that consumes C3.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Goodpasture&#39;s disease </strong>is<strong> not typically </strong>associated with <strong>low C3 levels</strong>. It is <strong>an autoimmune disease </strong>characterized by the presence of <strong>antibodies directed against the glomerular basement membrane and alveolar basement membrane </strong>in the lungs. This condition primarily involves the<strong> lungs and kidneys</strong>. While it can cause <strong>glomerulonephritis, </strong>it <strong>does not </strong>usually result in<strong> low C3 levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Post-streptococcal glomerulonephritis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This condition often follows a <strong>streptococcal infection </strong>and is characterized by an <strong>acute immune response</strong>. It leads to <strong>decreased </strong>levels of <strong>complement C3 </strong>due to the <strong>activation </strong>of the<strong> complement system</strong> by <strong>immune complexes</strong> deposited in the glomeruli.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Membranoproliferative glomerulonephritis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This <strong>chronic </strong>condition involves <strong>immune complexes and complement deposition </strong>in the kidneys, resulting in persistent<strong> low serum C3 levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Systemic lupus erythematosus (SLE):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> SLE is a <strong>systemic autoimmune disease </strong>that can cause a wide array of clinical manifestations, including <strong>lupus nephritis</strong>. <strong>Immune complexes </strong>formed in <strong>SLE activate </strong>the <strong>complement system</strong>, leading to reduced <strong>serum C3 levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Post-streptococcal glomerulonephritis and membranoproliferative glomerulonephritis </strong>commonly cause <strong>low serum C3 levels </strong>due to <strong>complement activation and consumption</strong>. In <strong>contrast</strong>,<strong> Goodpasture&rsquo;s disease does not </strong>typically result in <strong>low C3 levels </strong>as its pathogenesis <strong>does not </strong>involve immune complexes that <strong>activate complement. Systemic lupus erythematosus </strong>often presents with <strong>low C3 due to immune complex-mediated complement activation</strong>. </span></span></span></p>",
    "correct_choice_id": 59750,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 14932,
    "choices": [
      {
        "id": 59688,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hyaline degeneration</span></p>"
      },
      {
        "id": 59689,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hyperplastic arteriosclerosis</span></p>"
      },
      {
        "id": 59690,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Glomerulosclerosis</span></p>"
      },
      {
        "id": 59691,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Fibrillary glomerulonephritis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In a specimen of kidney, fibrinoid necrosis is seen and onion peel appearance is also present. Most probable pathology is:</span></p>",
    "unique_key": "Q1469193",
    "question_audio": null,
    "question_video": null,
    "map_id": 32099,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Hyperplastic arteriosclerosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/16/picture1_9ImuYlJ.jpg\" alt=\"\" width=\"1000\" height=\"273\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Hyaline degeneration </strong>refers to the accumulation of<strong> homogenous, eosinophilic material (hyaline) </strong>in tissues. It is not typically associated with fibrinoid necrosis or an onion peel appearance.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Glomerulosclerosis </strong>involves <strong>scarring and hardening of the glomeruli </strong>in the kidneys. It may not typically present with fibrinoid necrosis and an onion peel appearance.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>Fibrillary glomerulonephritis </strong>is a renal disease characterized by the<strong> deposition of fibrillary immune complexes </strong>in the <strong>glomeruli</strong>. Fibrinoid necrosis and an onion peel appearance are not typically associated with fibrillary glomerulonephritis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective</u></strong><u>:</u></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Hyperplastic arteriosclerosis </strong>is characterized by <strong>\"onion skin\" or \"string of beads</strong>\" appearance.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 935)</strong></i></span></p>",
    "correct_choice_id": 59689,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14942,
    "choices": [
      {
        "id": 59728,
        "text": "<p><span style=\"font-size:12pt;\">Rapidly progressive glomerulonephritis</span></p>"
      },
      {
        "id": 59729,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Alport syndrome</span></p>"
      },
      {
        "id": 59730,
        "text": "<p><span style=\"font-size:12pt;\">Goodpasture\u2019s syndrome</span></p>"
      },
      {
        "id": 59731,
        "text": "<p><span style=\"font-size:12pt;\">Henoch-Sch\u00f6nlein purpura</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 45-year-old man with a history of autoimmune disorders presents with fatigue, edema, and cola-colored urine. Laboratory studies reveal elevated serum creatinine, proteinuria, and hematuria. Urinalysis shows dysmorphic red blood cells and red cell casts. Renal biopsy reveals cellular crescents and fibrinoid necrosis in glomeruli. Which of these does not cause crescentic glomerulone\u00adphritis?</span></p>",
    "unique_key": "Q8571310",
    "question_audio": null,
    "question_video": null,
    "map_id": 32105,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Alport syndrome</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Alport syndrome </strong>is a <strong>genetic disorder </strong>caused by mutations in genes encoding <strong>type IV collagen</strong>. It primarily affects the<strong> kidneys, ears, and eyes. </strong>However, <strong>crescentic glomerulonephritis </strong>is <strong>not </strong>a characteristic feature of <strong>Alport syndrome</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Crescentic glomerulonephritis </strong>is a <strong>histopathological </strong>pattern of<strong> glomerular injury </strong>characterized by the presence of<strong> crescents in Bowman's space</strong>. Various diseases and conditions can cause crescentic glomerulonephritis. Let's look at the provided options:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong> <strong>Rapidly progressive glomerulonephritis (RPGN) </strong>is a term used to describe a<strong> clinical presentation </strong>rather than a <strong>specific disease. </strong>Conditions like <strong>ANCA-associated vasculitis, anti-GBM (Goodpasture's syndrome), and immune complex-mediated glomerulonephritis </strong>can present as <strong>RPGN with crescents.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Goodpasture's syndrome </strong>is an <strong>autoimmune disease </strong>characterized by the presence of <strong>anti-GBM antibodies</strong>. It can lead to <strong>rapidly progressive glomerulonephritis </strong>with <strong>crescent formation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>Henoch-Sch\u00f6nlein purpura (HSP) </strong>is a <strong>systemic vasculitis </strong>that affects <strong>small vessels</strong>, including glomerular capillaries. Crescentic glomerulonephritis can occur in some cases of HSP.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Alport syndrome </strong>does<strong> not </strong>cause <strong>crescentic glomerulone\u00adphritis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ p922)</strong></i></span></p>",
    "correct_choice_id": 59729,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14937,
    "choices": [
      {
        "id": 59708,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nodular glomerulosclerosis </span></span></span></p>"
      },
      {
        "id": 59709,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Focal necrotizing glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 59710,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Granulomas in the vascular wall </span></span></span></p>"
      },
      {
        "id": 59711,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Granuloma of parenchyma of kidney </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pathological feature in Wegener&rsquo;s granulomatosis on renal biopsy is?</span></span></span></p>",
    "unique_key": "Q1047280",
    "question_audio": null,
    "question_video": null,
    "map_id": 32100,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Focal necrotizing glomerulonephritis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Focal necrotizing glomerulonephritis </strong>is a <strong>hallmark of GPA</strong>. This reflects <strong>active glomerular inflammation and necrosis </strong>without significant<strong> immune deposits, </strong>characteristic of <strong>pauci-immune glomerulonephritis</strong>.</span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lsquo;The<strong> renal lesions </strong>range from a mild/ early disease, where <strong>glomeruli show acute focal necrosis with thrombosis </strong>of <strong>isolated glomerular capillary loops </strong>(focal and segmental necrotizing glomerulonephritis) whereas <strong>advanced glomerular lesions </strong>are characterized by <strong>diffuse necrosis and parietal cell proliferation </strong>to form <strong>crescents </strong>(crescentic glomerulonephritis)&rsquo;&hellip;&hellip;Robbins&nbsp; </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct quote from Harrison&hellip;&hellip;.. <strong>&ldquo;Necrotizing vas&shy;culitis of small arteries and veins </strong><em>with<strong> granuloma for&shy;mation </strong></em>is seen in <strong>pulmonary tissue </strong>whereas<strong> granu&shy;loma formation </strong>is <strong><em>rarely seen </em>on <em>renal biopsy&rdquo;. </em></strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Nodular glomerulosclerosis </strong>is<strong> not </strong>a typical feature of<strong> GPA.</strong> This finding is <strong>more commonly </strong>associated with <strong>diabetic nephropathy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>While granulomas </strong>are a defining feature of <strong>GPA, </strong>they are <strong>more </strong>commonly seen in<strong> pulmonary tissue </strong>and <strong>not </strong>as frequently observed within the <strong>vascular walls in the kidney </strong>on biopsy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Similar to option C,<strong> granulomas can be </strong>found in <strong>GPA </strong>but are <strong>more </strong>commonly<strong> identified in the respiratory tract </strong>than in the <strong>parenchyma of the kidney</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wegener&rsquo;s granulomatosis</strong>, or <strong>Granulomatosis with Polyangiitis</strong>, typically presents on <strong>renal biopsy </strong>with <strong>focal necrotizing glomerulonephritis</strong>, often with <strong>crescent formation</strong>, reflecting its classification as a form of <strong>pauci-immune glomerulonephritis. Granulomas</strong>, while a <strong>central feature in the lungs</strong>, are<strong> rarely seen in renal biopsies </strong>for this condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><em><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 910) </span></span></em></strong> </em></span></span></p>",
    "correct_choice_id": 59709,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14938,
    "choices": [
      {
        "id": 59712,
        "text": "<p><span style=\"font-size:12pt;\">Fibrin caps and capsular drops</span></p>"
      },
      {
        "id": 59713,
        "text": "<p><span style=\"font-size:12pt;\">Kimmelstein-Wilson lesion</span></p>"
      },
      {
        "id": 59714,
        "text": "<p><span style=\"font-size:12pt;\">Basement membrane thickening</span></p>"
      },
      {
        "id": 59715,
        "text": "<p><span style=\"font-size:12pt;\">Focal glomerular sclerosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Pathological changes of diabetic nephropathy are all except:</span></p>",
    "unique_key": "Q7871845",
    "question_audio": null,
    "question_video": null,
    "map_id": 32101,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Focal glomerular sclerosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Diabetic nephropathy </strong>is characterized by <strong>several pathological changes</strong>, and the options provided are associated with these changes:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Fibrin caps and capsular drops:</strong> These are characteristic of <strong>diabetic nephropathy</strong>. <strong>Fibrin caps</strong> are formed from the <strong>extravasation of plasma proteins </strong>into <strong>Bowman's space,</strong> and <strong>capsular drops are hyaline droplets</strong> in the<strong> renal tubules.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Kimmelstein-Wilson lesion:</strong> This refers to nodular <strong>glomerulosclerosis, </strong>which is a classic finding in <strong>diabetic nephropathy.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Basement membrane thickening:</strong> Thickening of the<strong> glomerular basement membrane </strong>is a <strong>hallmark of diabetic nephropathy</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Focal glomerular sclerosis (FSGS) </strong>is <strong>not a typical </strong>finding in <strong>diabetic nephropathy</strong>. It is a <strong>separate entity </strong>that can be associated with other conditions.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The characteristic pathological features of <strong>diabetic nephropathy</strong>, include <strong>Kimmelstiel-Wilson lesions (nodular glomerulosclerosis), thickening of the glomerular basement membrane</strong>, and <strong>the presence of fibrin caps and capsular drops</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 923)&nbsp;</strong></i></span></p>",
    "correct_choice_id": 59715,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14939,
    "choices": [
      {
        "id": 59716,
        "text": "<p><span style=\"font-size:12pt;\">Loss of antithrombin III (AT III)</span></p>"
      },
      {
        "id": 59717,
        "text": "<p><span style=\"font-size:12pt;\">Decreased fibrinogen</span></p>"
      },
      {
        "id": 59718,
        "text": "<p><span style=\"font-size:12pt;\">Decreased metabolism of vitamin K</span></p>"
      },
      {
        "id": 59719,
        "text": "<p><span style=\"font-size:12pt;\">Increase in Protein C</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">What is the cause of hypercoagulation in nephrotic syndrome?</span></p>",
    "unique_key": "Q6443227",
    "question_audio": null,
    "question_video": null,
    "map_id": 32102,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Loss of antithrombin III (AT III)</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Loss of antithrombin III (AT III):</strong> <strong>In nephrotic syndrome</strong>, there is<strong> increased urinary loss of proteins</strong> including <strong>antithrombin III</strong>, which is a <strong>natural anticoagulant</strong>. <strong>AT III </strong>inhibits <strong>thrombin and factor Xa </strong>in the<strong> coagulation cascade</strong>. Its <strong>loss </strong>contributes significantly to the <strong>hypercoagulable state in nephrotic syndrome.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Thrombotic and thromboembolic </strong>complications are com\u00admon in <strong>nephrotic syndrome due to loss of anticoagulant factor (e.g. antithrombin III, protein C and S) </strong>combined with<strong> increased platelet activation</strong>. <strong>Renal vein thrombo\u00adsis </strong>is most often a <strong>consequence </strong>of this<strong> hypercoagulative state</strong>. There is also <strong>increased synthesis of fibrinogen </strong>in the liver.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> hypercoagulable </strong>state in <strong>nephrotic syndrome </strong>is <strong>multifactorial</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Decreased fibrinogen:</strong> This statement is<strong> incorrect </strong>with respect to<strong> nephrotic syndrome</strong>. Actually, there is an<strong> increased synthesis of fibrinogen in the liver</strong>, <strong>not decreased</strong>. <strong>Fibrinogen </strong>is an <strong>acute phase reactant</strong>, and its levels are <strong>increased in nephrotic syndrome, </strong>which contributes to a<strong> hypercoagulable state</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Decreased metabolism of vitamin K:</strong> This statement is<strong> not </strong>directly related to the <strong>hypercoagulable </strong>state in <strong>nephrotic syndrome</strong>. <strong>Vitamin K </strong>is essential for the <strong>synthesis </strong>of certain clotting factors <strong>(II, VII, IX, X), </strong>and its<strong> metabolism </strong>can be <strong>affected </strong>in <strong>liver disease</strong>, <strong>not </strong>typically in<strong> nephrotic syndrome.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Increase in Protein C:</strong> This is <strong>not correct</strong>. While <strong>Protein C is an anticoagulant</strong>, similar to<strong> antithrombin III</strong>, in <strong>nephrotic syndrome</strong>, there can be a<strong> loss of Protein C through the urine, </strong>which would contribute to a<strong> hypercoagulable state </strong>rather than <strong>mitigating it</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Nephrotic syndrome </strong>is associated with a <strong>hypercoagulable state </strong>primarily due to <strong>urinary losses of anticoagulant proteins </strong>such as <strong>antithrombin III</strong>, often leading to thrombotic complications like <strong>renal vein thrombosis</strong>. The <strong>liver's increased synthesis of procoagulant </strong>factors such as<strong> fibrinogen also contributes </strong>to this state.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10h/ 911)</strong></i></span></p>",
    "correct_choice_id": 59716,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14940,
    "choices": [
      {
        "id": 59720,
        "text": "<p><span style=\"font-size:12.0pt;\">Nephrin</span></p>"
      },
      {
        "id": 59721,
        "text": "<p><span style=\"font-size:12pt;\">Podocin</span></p>"
      },
      {
        "id": 59722,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Alpha actinin</span></p>"
      },
      {
        "id": 59723,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">CD2 activated protein</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Finnish type of nephrotic syndrome is associated with:</span></p>",
    "unique_key": "Q9890443",
    "question_audio": null,
    "question_video": null,
    "map_id": 32103,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Nephrin</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Nephrin:</strong> Nephrin is a<strong> key structural and signaling protein </strong>that is part of the<strong> slit diaphragm of glomerular podocytes </strong>in the kidney. <strong>Mutations </strong>in the gene encoding nephrin<strong> (NPHS1) </strong>are responsible for <strong>Finnish-type congenital nephrotic syndrome</strong>. This condition is characterized by <strong>massive proteinuria </strong>starting in<strong> utero or shortly after birth </strong>and often <strong>leads to renal failure</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Lipoid nephrosis </strong>or<strong> nephrotic syndrome </strong>is also called as <strong>minimal change disease</strong>.<strong> Congenital nephrotic syndrome </strong>occurs as a result of<strong> mutation </strong>in the <strong>nephrin </strong>gene. (<strong>Finnish type of nephrotic syndrome</strong>)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Podocin:</strong> Podocin is another <strong>protein </strong>that is important in the structure of the <strong>slit diaphragm of podocytes</strong>. <strong>Mutations </strong>in the gene encoding podocin<strong> (NPHS2) </strong>cause <strong>autosomal recessive steroid-resistant nephrotic syndrome</strong>, which is <strong>different from </strong>the <strong>Finnish type </strong>but also results in significant <strong>proteinuria.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Alpha-actinin:</strong> Alpha-actinin is a <strong>cytoskeletal actin-binding protein </strong>that is involved in maintaining the structure of the <strong>podocyte foot processes </strong>and the <strong>slit diaphragm</strong>. Mutations here can also cause<strong> nephrotic syndrome</strong>, but they are <strong>not </strong>associated with the <strong>Finnish type of nephrotic syndrome</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: CD2-associated protein (CD2AP):</strong> CD2AP is a molecule involved in the <strong>structure and function of the slit diaphragm </strong>and the <strong>actin cytoskeleton in podocytes</strong>. <strong>Mutations in CD2AP </strong>can lead to <strong>nephrotic syndrome</strong>, <strong>highlighting </strong>its role in<strong> maintaining </strong>the <strong>glomerular filtration barrier.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Finnish type nephrotic syndrome </strong>is caused by<strong> mutations </strong>in the<strong> nephrin gene.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QY44t94.png\" width=\"1428\" height=\"394\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 915)</strong></span></p>",
    "correct_choice_id": 59720,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14941,
    "choices": [
      {
        "id": 59724,
        "text": "<p><span style=\"font-size:12pt;\">Granulomatosis with polyangiitis</span></p>"
      },
      {
        "id": 59725,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">SLE</span></p>"
      },
      {
        "id": 59726,
        "text": "<p><span style=\"font-size:12pt;\">Henoch Schonlein Purpura</span></p>"
      },
      {
        "id": 59727,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Polyarteritis nodosa</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Pauci-immune crescentic glomerulonephritis is associated with:</span></p>",
    "unique_key": "Q3539335",
    "question_audio": null,
    "question_video": null,
    "map_id": 32104,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. A)&nbsp;Granulomatosis with polyangiitis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Granulomatosis with polyangiitis (GPA):</strong> GPA is closely associated with pauci-immune crescentic glomerulonephritis, which is a type of inflammation of the kidney that does not involve significant deposits of immune complexes or antibodies. ANCA, particularly c-ANCA with PR3 specificity, is commonly found in patients with GPA.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Pauci-immune crescentic glomerulonephritis is most commonly associated with ANCA (antineutrophil cytoplasmic antibody)-associated vasculitides. Granulomatosis with polyangiitis (GPA), formerly known as Wegener's granulomatosis, is one of the ANCA-associated vasculitides and is strongly associated with pauci-immune crescentic glomerulonephritis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">The association of pauci-immune crescentic glomerulonephritis:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B: Systemic lupus erythematosus (SLE):</strong> SLE can affect the kidneys, leading to lupus nephritis, which often involves the deposition of immune complexes. Therefore, it is not typically classified as pauci-immune.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C: Henoch-Schonlein purpura (HSP):</strong> HSP is characterized by the deposition of IgA immune complexes, particularly affecting the small vessels, and it can lead to a type of crescentic glomerulonephritis but it is not pauci-immune.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D: Polyarteritis nodosa (PAN):</strong> PAN is a systemic necrotizing vasculitis that can affect medium-sized arteries and may cause renal damage. However, it is not primarily associated with pauci-immune crescentic glomerulonephritis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Pauci-immune crescentic glomerulonephritis is a form of rapidly progressing glomerulonephritis strongly associated with ANCA-associated vasculitides, particularly granulomatosis with polyangiitis. It is characterized by minimal or no immune complex deposition and can be differentiated from other forms of crescentic glomerulonephritis by the lack of significant immune deposits.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Type I RPGN = <strong>anti-GBM disease</strong> (Goodpasture\u2019s).&nbsp;</span></li><li><span style=\"font-size:16px;\">Type II RPGN = <strong>immune complex-mediated</strong> (SLE, IgA nephropathy, post-infectious)</span></li><li><span style=\"font-size:16px;\">Type III RPGN = <strong>pauci-immune</strong> (ANCA-associated vasculitis)</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 910)</strong></span></p>",
    "correct_choice_id": 59724,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14943,
    "choices": [
      {
        "id": 59732,
        "text": "<p><span style=\"font-size:12pt;\">Membranous glomerulonephritis</span></p>"
      },
      {
        "id": 59733,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mesangiocapillary glomerulonephritis</span></p>"
      },
      {
        "id": 59734,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Diabetic glomerulosclerosis</span></p>"
      },
      {
        "id": 59735,
        "text": "<p><span style=\"font-size:12.0pt;\">Amyloidosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">All are non-proliferative glomerulonephritis, except:</span></p>",
    "unique_key": "Q8682852",
    "question_audio": null,
    "question_video": null,
    "map_id": 32106,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Mesangiocapillary glomerulonephritis &nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Mesangiocapillary glomerulonephritis:</strong> This condition, also known as<strong> type I membranoproliferative glomerulonephritis</strong>, is indeed a <strong>proliferative </strong>type. It's characterized by <strong>hypercellularity </strong>involving both <strong>mesangial cells and capillary loops</strong>, along with changes in the <strong>basement membrane and mesangial matrix.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Glomerular lesions </strong>with <strong>increased cells </strong>in the <strong>tufts</strong> are often known as <strong>proliferative glomerulonephritis</strong>. The following are the conditions with proliferative glomerulonephritis</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/16/picture3_7Tma1fD.jpg\" alt=\"\" width=\"1000\" height=\"183\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Membranous glomerulonephritis:</strong> This is a type of<strong> non-proliferative glomerulonephritis </strong>characterized by the <strong>thickening </strong>of the <strong>glomerular basement membrane </strong>without an increase in the number of cells<strong> (non-proliferative). </strong>It is often associated with the presence of <strong>immune complexes along the basement membrane.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Diabetic glomerulosclerosis:</strong> This refers to<strong> changes in the kidneys </strong>associated with <strong>diabetes mellitus </strong>and is characterized by <strong>thickening of the basement membrane and mesangial expansion</strong>. It <strong>does not </strong>involve an <strong>increase </strong>in the <strong>number of glomerular cells </strong>and is therefore considered <strong>non-proliferative</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Amyloidosis:</strong> Amyloidosis in the<strong> kidney </strong>leads to the deposition of <strong>amyloid proteins </strong>in the <strong>glomerulus. </strong>It is also<strong> non-proliferative</strong>, as it does not involve an increase in glomerular cell number.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Proliferative glomerulonephritis </strong>is defined by an<strong> increase in cellular elements </strong>within the<strong> glomerular structure</strong>, which is evident in <strong>mesangiocapillary glomerulonephritis</strong></span></p></li><li><span style=\"font-size:12pt;\">Non-proliferative: membranous glomerulonephritis, diabetic glomerulosclerosis, and amyloidosis.</span></li></ul><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Anderson 10<sup>th</sup> /917)</strong></span></p>",
    "correct_choice_id": 59733,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14944,
    "choices": [
      {
        "id": 59736,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Thrombotic microangiopathy</span></p>"
      },
      {
        "id": 59737,
        "text": "<p><span style=\"font-size:12pt;\">Proliferative glomerulonephritis</span></p>"
      },
      {
        "id": 59738,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Focal segmental glomerulosclerosis</span></p>"
      },
      {
        "id": 59739,
        "text": "<p><span style=\"font-size:12pt;\">Minimal change disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Kidney biopsy from a child with hemolytic uremic syndrome characteristically most likely presents features of:</span></p>",
    "unique_key": "Q9336541",
    "question_audio": null,
    "question_video": null,
    "map_id": 32107,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Thrombotic microangiopathy</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Thrombotic Microangiopathy:</strong> This is the correct diagnosis for<strong> hemolytic uremic syndrome (HUS). </strong>It involves the presence of <strong>microthrombi in the small blood vessels </strong>of the kidney, which leads to<strong> mechanical damage to red blood cells </strong>as they <strong>pass </strong>through the <strong>partially occluded vessels</strong>, causing a characteristic type of <strong>anemia </strong>known as <strong>microangiopathic hemolytic anemia</strong>, along with <strong>thrombocytopenia </strong>due to<strong> platelet consumption and acute kidney injury.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Proliferative Glomerulonephritis:</strong> This involves an <strong>increase </strong>in the<strong> number of cells </strong>in the<strong> glomeruli</strong>, typically due to an <strong>immune or inflammatory response</strong>. It is <strong>not </strong>typically associated with <strong>HUS</strong>, which is characterized by<strong> microangiopathic changes </strong>rather than cellular proliferation in the glomeruli.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Focal Segmental Glomerulosclerosis (FSGS):</strong> This condition is characterized by <strong>segments of the glomeruli </strong>showing <strong>scarring</strong>, which can lead to<strong> proteinuria and nephrotic syndrome</strong>. While<strong> FSGS </strong>can result in <strong>renal failure</strong>, it is<strong> not </strong>a characteristic feature of <strong>HUS.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Minimal Change Disease:</strong> This is a kidney disorder that causes<strong> nephrotic syndrome</strong>, especially in<strong> children</strong>, and is characterized by <strong>minimal changes </strong>detectable by <strong>light microscopy</strong>. It's associated with<strong> good prognosis </strong>and typically <strong>responds </strong>well to <strong>steroids.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>patients </strong>presenting with the clinical triad of<strong> microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury</strong>, a kidney biopsy is likely to reveal <strong>thrombotic microangiopathy, </strong>a pathology characteristic of<strong> hemolytic uremic syndrome</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 939)</strong></i></span></p>",
    "correct_choice_id": 59736,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14945,
    "choices": [
      {
        "id": 59740,
        "text": "<p><span style=\"font-size:12pt;\">Post streptococcal glomerulonephritis</span></p>"
      },
      {
        "id": 59741,
        "text": "<p><span style=\"font-size:12pt;\">Membranoproliferative glomerulonephritis type II</span></p>"
      },
      {
        "id": 59742,
        "text": "<p><span style=\"font-size:12pt;\">Lupus nephritis</span></p>"
      },
      {
        "id": 59743,
        "text": "<p><span style=\"font-size:12pt;\">Glomerulonephritis related to bacterial endocarditis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Serum C3 is persistently low in the following except:</span></p>",
    "unique_key": "Q2609140",
    "question_audio": null,
    "question_video": null,
    "map_id": 32108,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Post streptococcal glomerulonephritis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Post Streptococcal Glomerulonephritis:</strong> After an infection with certain <strong>strains of Streptococcus, serum C3 </strong>levels typically <strong>decrease </strong>due to activation of the<strong> complement system</strong>. However, this<strong> decrease is transient and serum C3 levels </strong>usually <strong>normalize </strong>within <strong>6 to 8 weeks</strong>. Therefore, persistently<strong> low serum C3 levels </strong>are<strong> not </strong>characteristic of <strong>poststreptococcal glomerulonephritis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The terms of serum C3 levels in different renal pathologies:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Membranoproliferative Glomerulonephritis type II:</strong> This condition can cause persistently <strong>low serum C3 levels</strong>, often related to the presence of<strong> C3 nephritic factors </strong>that continuously activate the <strong>alternative complement pathway, </strong>leading to <strong>complement consumption</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Lupus Nephritis:</strong> In <strong>systemic lupus erythematosus (SLE), </strong>including <strong>lupus nephritis</strong>, both <strong>classical and alternative complement pathways </strong>can be activated by <strong>immune complexes</strong>, leading to persistent<strong> depression of complement components</strong>, including<strong> C3</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Glomerulonephritis Related to Bacterial Endocarditis:</strong> This condition is also associated with<strong> immune complex deposition </strong>that can <strong>consume complement</strong>. Persistent<strong> low serum C3 </strong>levels may be observed, depending on the<strong> chronicity and activity of the infection</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Serum complement levels</strong>, specifically<strong> C3</strong>, can be a valuable clinical marker in the <strong>diagnosis and monitoring of glomerular diseases. Poststreptococcal glomerulonephritis </strong>typically presents with<strong> transient low serum C3 levels, </strong>which recover<strong> within a few weeks</strong>, unlike other conditions such as<strong> membranoproliferative glomerulonephritis, lupus nephritis, and glomerulonephritis </strong>related to <strong>bacterial endocarditis, </strong>which may show <strong>persistent low levels </strong>indicative of ongoing<strong> complement activation and consumption.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">C3 Levels in Different Types of GN:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8iXZzjK.png\" width=\"1301\" height=\"586\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup> 906)</strong></span></p>",
    "correct_choice_id": 59740,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14948,
    "choices": [
      {
        "id": 59752,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pathological changes are proliferative and usu&shy;ally confined to mesangial cells; usually focal and segmental</span></span></span></p>"
      },
      {
        "id": 59753,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hematuria may be gross or microscopic </span></span></span></p>"
      },
      {
        "id": 59754,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">On immunofluorescence deposits contain with IgA and IgG </span></span></span></p>"
      },
      {
        "id": 59755,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absence of associated proteinuria is pathognomic </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man presents to the clinic with recurrent episodes of gross hematuria following upper respiratory tract infections. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not true about Berger&rsquo;s disease?<em> </em></span></span></span></p>",
    "unique_key": "Q9847886",
    "question_audio": null,
    "question_video": null,
    "map_id": 32111,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Absence of associated proteinuria is pathogno&shy;mic </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>absence of proteinuria </strong>is<strong> not </strong>pathognomonic for <strong>Berger&rsquo;s disease</strong>; on the contrary, <strong>proteinuria </strong>can be <strong>present and varies in severity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Berger&#39;s disease</strong>, also known as <strong>IgA nephropathy</strong>, is characterized by the deposition of<strong> IgA immune complexes </strong>in the<strong> glomerular mesangium</strong>. While it is <strong>true </strong>that <strong>Berger&#39;s disease </strong>often presents<strong> with hematuria </strong>(either gross or microscopic), the <strong>absence of associated proteinuria is not pathognomonic. </strong>In fact,<strong> proteinuria </strong>can occur in <strong>some cases of IgA nephropathy, </strong>and the severity can vary. <strong>Proteinuria </strong>is<strong> not </strong>consistently <strong>absent in Berger&#39;s disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Berger&rsquo;s disease, or IgA nephropathy, </strong>indeed shows<strong> mesangial proliferation. </strong>This is often a<strong> focal and segmental process </strong>within the <strong>glomeruli </strong>and is characteristic of the disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Hematuria</strong>, which may be<strong> gross (visible) or microscopic</strong>, is a common finding in Berger&#39;s disease and can be one of the initial signs of the condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Immunofluorescence </strong>typically shows <strong>mesangial deposits primarily composed of IgA</strong>, and sometimes <strong>IgG and C3 </strong>may be present. The predominance o<strong>f IgA deposition </strong>is a defining feature of <strong>IgA nephropathy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> characteristic </strong>pathological feature of <strong>Berger&rsquo;s disease </strong>is the deposition of<strong> IgA immune complexes </strong>in the<strong> glomerular mesangium</strong>. <strong>IgA nephropathy </strong>can present with a<strong> range of symptoms </strong>from <strong>isolated hematuria to nephrotic syndrome </strong>with significant <strong>proteinuria. </strong>A <strong>lack of proteinuria </strong>is<strong> not diagnostic of the disease. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> /920)</span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><em><span style=\"font-size:12.0pt\"><span style=\"color:black\"> </span></span></em></span></span></p>",
    "correct_choice_id": 59755,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14950,
    "choices": [
      {
        "id": 59760,
        "text": "<p><span style=\"font-size:12pt;\">Glomerular granuloma</span></p>"
      },
      {
        "id": 59761,
        "text": "<p><span style=\"font-size:12pt;\">Interstitial granuloma</span></p>"
      },
      {
        "id": 59762,
        "text": "<p><span style=\"font-size:12pt;\">Crescentic glomerulonephritis</span></p>"
      },
      {
        "id": 59763,
        "text": "<p><span style=\"font-size:12.0pt;\">Glomerulosclerosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 40-year-old man presents with a 3-month history of recurrent sinusitis, cough, and hemoptysis. Physical examination reveals saddle-nose deformity and purpuric skin lesions on the lower extremities. Laboratory studies show elevated inflammatory markers and positive anti-neutrophil cytoplasmic antibodies (c-ANCA). In Wegener\u2019s granulomatosis, kidney has which of the following lesions?</span></p>",
    "unique_key": "Q1929777",
    "question_audio": null,
    "question_video": null,
    "map_id": 32113,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Crescentic glomerulonephritis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Wegener's granulomatosis </strong>often presents with <strong>necrotizing granulomatous inflammation </strong>in the <strong>respiratory tract and necrotizing vasculitis </strong>affecting<strong> small- to medium-sized vessels. </strong>In the kidney, this <strong>vasculitis </strong>can lead to<strong> crescentic glomerulonephritis, </strong>which is a characteristic renal manifestation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Options A:&nbsp;</strong>and <strong>Option C:</strong> <strong>glomerular and interstitial granuloma </strong>is <strong>not </strong>a typical finding in <strong>Wegener's granulomatosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Wegener's granulomatosis </strong>primarily involves<strong> small vessels </strong>and may cause <strong>granulomatous inflammation </strong>in the <strong>interstitial tissues</strong>, but<strong> glomerular and interstitial granulomas </strong>are<strong> not a defining feature</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>Glomerulosclerosis </strong>is<strong> not </strong>a typical lesion seen in<strong> Wegener's granulomatosis</strong>. The primary renal involvement is characterized by <strong>crescentic glomerulonephritis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>Wegener\u2019s granulomatosis </strong>kidney shows<strong> crescentic glomerulonephritis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/909)</strong></i></span></p>",
    "correct_choice_id": 59762,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14951,
    "choices": [
      {
        "id": 59764,
        "text": "<p><span style=\"font-size:12pt;\">Goodpasture syndrome</span></p>"
      },
      {
        "id": 59765,
        "text": "<p><span style=\"font-size:12pt;\">Churg-Strauss syndrome</span></p>"
      },
      {
        "id": 59766,
        "text": "<p><span style=\"font-size:12pt;\">Alport syndrome</span></p>"
      },
      {
        "id": 59767,
        "text": "<p><span style=\"font-size:12pt;\">Wegner\u2019s granulomatosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The electron microscopy is virtually diagnostic in renal biopsy study of:</span></p>",
    "unique_key": "Q7096963",
    "question_audio": null,
    "question_video": null,
    "map_id": 32114,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Alport syndrome</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Alport syndrome </strong>shows a characteristic <strong>electron </strong>microscopy finding of the <strong>glomerular basement membrane (GBM), </strong>which is described as<strong> basket-weaving</strong>, due to <strong>splitting and lamellation of the lamina densa</strong>. This is a pathognomonic feature.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/16/picture5_o1fYjWl.jpg\" alt=\"\" width=\"1000\" height=\"348\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;Goodpasture syndrome </strong>is characterized by the presence of <strong>anti-GBM antibodies </strong>leading to <strong>glomerulonephritis and pulmonary hemorrhage</strong>. <strong>Electron microscopy </strong>may show<strong> non-specific findings </strong>of glomerular damage rather than the <strong>specific changes seen in Alport syndrome.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;Churg-Strauss syndrome, </strong>also known as<strong> eosinophilic granulomatosis with polyangiitis</strong>, is a form of <strong>vasculitis.</strong> <strong>Renal involvement can occur</strong>, but electron microscopy findings are <strong>not diagnostic </strong>of the condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Wegener\u2019s granulomatosis, now known as granulomatosis with polyangiitis</strong>, may show evidence of<strong> small vessel vasculitis on biopsy</strong>, but electron microscopy is<strong> not typically diagnostic </strong>for this condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Alport syndrome's </strong>definitive <strong>morphological lesions </strong>are observable only by <strong>electron microscopy</strong>, which reveals a <strong>distinctive appearance of the GBM.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 922)</strong></i></span></p>",
    "correct_choice_id": 59766,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14954,
    "choices": [
      {
        "id": 59776,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangioproliferative glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 59777,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Focal and segmental glomerulosclerosis </span></span></span></p>"
      },
      {
        "id": 59778,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kimmelstiel-Wilson lesions </span></span></span></p>"
      },
      {
        "id": 59779,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amyloidosis </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangial deposits of monoclonal kappa/lambda light chains in indicative of?</span></span></span></p>",
    "unique_key": "Q3903273",
    "question_audio": null,
    "question_video": null,
    "map_id": 32117,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Amyloidosis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Amyloidosis </strong>is the <strong>correct</strong> answer, as it is specifically associated with the deposition of <strong>abnormal proteins</strong>, including <strong>AL proteins made of immunoglobulin light chains</strong>, within the<strong> kidney and other organs</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangial deposits of <strong>monoclonal kappa/lambda </strong>light chains suggest the diagnosis of <strong>Amyloidosis. </strong>In primary Amyloidosis <strong>AL protein </strong>is deposited in the <strong>organs, </strong>which is made of<strong> light chains (usually lambda type) of immunoglobulins</strong>. <strong>Renal amyloi&shy;dosis </strong>is the <strong>most common cause of death due to amyloidosis </strong>(including both primary and second&shy;ary amyloidosis).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Mesangioproliferative glomerulonephritis </strong>involves <strong>proliferation </strong>of <strong>mesangial cells </strong>within the<strong> kidney </strong>but is not specifically associated with the deposition of light chains.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Focal and segmental glomerulosclerosis (FSGS) </strong>is characterized by <strong>segments of scarring in some glomeruli </strong>but <strong>does not </strong>feature <strong>light chain deposits</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Kimmelstiel-Wilson lesions </strong>are specific to <strong>diabetic nephropathy </strong>and exhibit <strong>nodular glomerulosclerosis, </strong>which also <strong>does not </strong>involve <strong>monoclonal light chains</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Renal amyloidosis </strong>can present with <strong>mesangial deposits </strong>of<strong> monoclonal kappa or lambda light chains </strong>and is associated with <strong>primary amyloidosis</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 934)</span></span></em></strong></span></span></span></p>",
    "correct_choice_id": 59779,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 14966,
    "choices": [
      {
        "id": 59824,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Of its high concentration in plasma </span></span></span></p>"
      },
      {
        "id": 59825,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Has molecular weight slightly greater than the mol&shy;ecules normally getting filtered </span></span></span></p>"
      },
      {
        "id": 59826,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">High Albumin Globulin ratio </span></span></span></p>"
      },
      {
        "id": 59827,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tubular epithelial cells are sensitive to albumin </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In renal disease, albumin is first to appear in urine because?</span></span></span></p>",
    "unique_key": "Q2725440",
    "question_audio": null,
    "question_video": null,
    "map_id": 32118,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Has molecular weight slightly greater than the molecules normally getting filtered </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The molecular weight of<strong> albumin is slightly greater </strong>than that of <strong>molecules normally filtered</strong>; however, <strong>albumin is still small </strong>enough (around<strong> 7nm </strong>in diameter) to be filtered if the<strong> charge barrier is compromised.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>filtration </strong>of any substance through<strong> glomerular filtration </strong>layer depends on <strong>two </strong>factors as described below: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/16/picture6_MHyFwW6.jpg\" style=\"height:323px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In some renal diseases, the <strong>anionic charge of the fil&shy;tration membrane is lost </strong>and this allows negatively charged particles of diameter <strong>8 nm </strong>to pass through it resulting in proteinuria. Albumin has a diameter of <strong>7 nm </strong>and it <em>starts appearing in urine as soon as the negative charge of filtration layer disappears. </em></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> High concentration </strong>in plasma <strong>does not </strong>inherently cause <strong>albumin to be filtered into the urine</strong>; it is the <strong>selectivity of the glomerular filter </strong>that is important.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> albumin-globulin ratio </strong>in the blood <strong>does not </strong>affect the <strong>selectivity of the glomerular filtration barrier directly</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Tubular reabsorption and sensitivity to albumin </strong>do not primarily determine its filtration, although <strong>damage to tubular cells </strong>can contribute to<strong> proteinuria </strong>if they are <strong>unable to reabsorb filtered proteins.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The main reason<strong> albumin </strong>is the <strong>first </strong>to appear in <strong>urine </strong>during renal disease is due to<strong> its size and charge</strong>. Normally, <strong>albumin is repelled </strong>by the <strong>negatively charged glomerular basement membrane</strong>, but when the <strong>charge barrier is lost due to renal disease, albumin can pass </strong>through <strong>more easily</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 911)</span></span></em></strong></p>",
    "correct_choice_id": 59825,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14968,
    "choices": [
      {
        "id": 59832,
        "text": "<p><span style=\"font-size:12pt;\">Fusion of foot processes of the glomerular epithelial cells</span></p>"
      },
      {
        "id": 59833,
        "text": "<p><span style=\"font-size:12pt;\">Rarefaction of glomerular basement membrane</span></p>"
      },
      {
        "id": 59834,
        "text": "<p><span style=\"font-size:12pt;\">Deposition of electron dense material in the basement membrane</span></p>"
      },
      {
        "id": 59835,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Thin basement membrane</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 7 year old boy presented with generalized edema. Urine examination revealed marked albuminuria. Serum biochemical examinations showed hypoalbuminemia with hyperlipidemia. Kidney biopsy was undertaken. On light microscopic examination, the kidney appeared normal. Electron microscopic examination is most likely to reveal:</span></p>",
    "unique_key": "Q4088833",
    "question_audio": null,
    "question_video": null,
    "map_id": 32119,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Fusion of foot process of the glomerular epi\u00adthelial cells</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Fusion of foot processes </strong>of the <strong>glomerular epithelial cells </strong>is characteristic of <strong>minimal change disease</strong>. <strong>Electron microscopy </strong>will reveal<strong> effacement or fusion of the podocyte foot processes </strong>without<strong> immune complex deposition or complement activation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> child is presenting </strong>with features likely of <strong>Nephrotic syndrome </strong>whose most frequent cause in <strong>children is minimal change disease </strong>or<strong> lipoid nephrosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Light microscopy </strong>there is <strong>no abnormality </strong>whereas on <strong>electron microscopy </strong>there is <strong>fusion of foot pro\u00adcesses of the glomerular epithelial cells </strong>with normal glomeruli.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>Rarefaction of the glomerular basement membrane </strong>is <strong>not </strong>a feature of <strong>MCD </strong>but may be seen in other kidney diseases, such as Alport syndrome.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Deposition of electron-dense material in the basement membrane </strong>is typically observed in diseases such as <strong>membranous nephropathy</strong>, not MCD.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> A <strong>thin basement membrane </strong>is characteristic of <strong>thin basement membrane disease</strong>, a condition separate from MCD.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The primary finding in <strong>minimal change disease on electron microscopy </strong>is the<strong> effacement or fusion of podocyte foot processes, </strong>which helps in<strong> distinguishing it </strong>from <strong>other glomerular diseases </strong>that may present with<strong> normal findings on light microscopy </strong>but show <strong>specific abnormalities on electron microscopy.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 914)</strong></i></span></p>",
    "correct_choice_id": 59832,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14969,
    "choices": [
      {
        "id": 59836,
        "text": "<p><span style=\"font-size:12pt;\">Number of crescents</span></p>"
      },
      {
        "id": 59837,
        "text": "<p><span style=\"font-size:12pt;\">Size of crescents</span></p>"
      },
      {
        "id": 59838,
        "text": "<p><span style=\"font-size:12pt;\">Shape of crescents</span></p>"
      },
      {
        "id": 59839,
        "text": "<p><span style=\"font-size:12pt;\">Cellularity of crescents</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The prognosis of rapidly proliferating glomerulonephritis depends upon which of the following?</span></p>",
    "unique_key": "Q8026495",
    "question_audio": null,
    "question_video": null,
    "map_id": 32120,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Number of crescents</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>The Number of Crescents</strong>: This is the most important <strong>prognostic factor </strong>in <strong>rapidly proliferating glomerulonephritis. </strong>The <strong>more glomeruli </strong>that contain <strong>crescents, </strong>especially when <strong>more than 50% </strong>of the <strong>glomeruli </strong>are involved, the <strong>worse the prognosis </strong>is likely to be due to the associated <strong>reduction in functional renal tissue</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Crescents </strong>are formed by the <strong>proliferation of cells in Bowman's space </strong>(glomerular parietal epithelial cells, infiltrating monocytes/macrophages, and other cells). The presence of<strong> crescents </strong>indicates <strong>severe glomerular injury and inflammation</strong>, and the <strong>degree of crescent formation </strong>correlates with the <strong>extent of damage</strong>. The<strong> more crescents present</strong>, the greater the <strong>loss of functional glomerular tissue</strong>, leading to<strong> impaired kidney function </strong>and<strong> poorer prognosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Size of Crescents:</strong> While the<strong> size of crescents </strong>might reflect the<strong> severity of the initial injury</strong>, it is <strong>not </strong>as directly correlated with the<strong> prognosis </strong>as the <strong>number of affected glomeruli.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Shape of Crescents:</strong> The <strong>shape does not </strong>typically provide<strong> prognostic information</strong>. Crescents, by definition, are <strong>semi-lunar and their presence</strong>, regardless of shape, suggests <strong>significant pathology.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Cellularity of Crescents</strong>: Cellularity can give clues about the <strong>activity of the disease process </strong>(more cellular crescents may indicate more active disease), but again, the<strong> number of crescents is a stronger prognostic indicator</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In<strong> rapidly proliferating glomerulonephritis, </strong>the prognosis is primarily dependent on the<strong> number of crescents within the glomeruli</strong>, as this reflects the <strong>degree of glomerular damage and potential loss of kidney function</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 909)</strong></i></span></p>",
    "correct_choice_id": 59836,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14982,
    "choices": [
      {
        "id": 59888,
        "text": "<p><span style=\"font-size:12pt;\">Epithelial cells + fibrin + macrophage</span></p>"
      },
      {
        "id": 59889,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mesangial cell + fibrin + macrophage</span></p>"
      },
      {
        "id": 59890,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Tubular cell + mesangial cell + fibrin</span></p>"
      },
      {
        "id": 59891,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Neutrophil + tubular cell + fibrin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Crescents are derived from which of the following?</span></p>",
    "unique_key": "Q7502690",
    "question_audio": null,
    "question_video": null,
    "map_id": 32089,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Epithelial cells + fibrin + macrophage</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Epithelial cells + fibrin + macrophage Crescents </strong>are formed within <strong>Bowman's space </strong>during severe <strong>glomerular injury.</strong> <strong>Parietal</strong> <strong>epithelial cells line Bowman's capsule, </strong>and they proliferate in response to<strong> injury. Macrophages infiltrate</strong> the space as part of the inflammatory response, and <strong>fibrin is deposited </strong>due to the leakage of<strong> plasma proteins through the injured glomerular capillaries</strong>. This option <strong>correctly identifies </strong>the components of a <strong>crescent in proliferative forms of glomerulonephritis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The composition of crescents in glomerulonephritis:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Mesangial cell + fibrin + macrophage</strong>.&nbsp; While<strong> mesangial cells </strong>are indeed a<strong> component of the glomerulus </strong>and can <strong>proliferate in response to injury</strong>, they are <strong>not </strong>typically a part of the<strong> cellular makeup of crescents. Crescents are primarily </strong>composed of <strong>parietal epithelial cells</strong>, not mesangial cells.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Tubular cell + mesangial cell + fibrin Tubular cells </strong>are part of the <strong>nephron </strong>but <strong>not of the glomerulus</strong>, and they <strong>do not </strong>contribute to<strong> crescent formation</strong>. <strong>Mesangial cells</strong>, as mentioned earlier, <strong>reside within the glomerulus </strong>but <strong>do not form crescents.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>Neutrophil + tubular cell + fibrin Neutrophils </strong>may be present in the<strong> glomerulus as part of an inflammatory response </strong>but are<strong> not </strong>a defining component of<strong> crescents</strong>. <strong>Tubular cells </strong>are<strong> not </strong>involved in <strong>crescent formation</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>Crescents </strong></i>are formed by proliferation of <strong>parietal cells </strong>and by <strong>migration of monocytes and macrophages </strong>into the urinary space. <strong>Neutrophils and lymphocytes </strong>may be present. <strong>Fibrin strands </strong>are frequently promi\u00adnent <strong>between the cellular layers in the crescents. </strong>The escape of<strong> fibrinogen </strong>into Bowman space and its <strong>conver\u00adsion to fibrin </strong>are an important contributor to<strong> crescent formation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 911)&nbsp;</strong></i></span></p>",
    "correct_choice_id": 59888,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14983,
    "choices": [
      {
        "id": 59892,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Malignant hypertension</span></p>"
      },
      {
        "id": 59893,
        "text": "<p><span style=\"font-size:12pt;\">Benign hypertension</span></p>"
      },
      {
        "id": 59894,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Chronic pyelonephritis</span></p>"
      },
      {
        "id": 59895,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Diabetes mellitus</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Flea bitten appearance of the kidney is seen in:</span></p>",
    "unique_key": "Q5302374",
    "question_audio": null,
    "question_video": null,
    "map_id": 32090,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Malignant hypertension</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture3.jpg\" alt=\"\" width=\"1000\" height=\"330\"></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Benign hypertension</strong>, also known as <strong>essential hypertension</strong>, is associated with<strong> long-standing high blood pressure</strong>. It can lead to <strong>hypertensive nephrosclerosis, </strong>characterized by <strong>arteriolar hyalinosis and ischemic </strong>changes in the <strong>kidney. </strong>However, \"flea-bitten\" appearance is not a specific term associated with this condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Chronic pyelonephritis </strong>is a condition characterized by<strong> chronic inflammation of the renal parenchyma</strong>, often <strong>secondary to recurrent urinary tract infections</strong>. It typically presents with <strong>scarring and atrophy of the renal papillae</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>Long standing </strong>and <strong>uncontrolled diabetes </strong>can lead to <strong>diabetic nephropathy. </strong>This condition is characterized by<strong> glomerular basement membrane thickening and nodular glomerulosclerosis</strong> (Kimmelstiel-Wilson nodules).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Mnemonic for differential diagnosis of flea bitten kid\u00adney: We HaTe PSM</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>W</strong>e -Wegener\u2019s granulomatosis</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>H</strong>a<strong>T</strong>e <strong>\u2013 H</strong>enoch Schonlein purpura; <strong>H</strong>US;<strong>T</strong>TP</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>P- P</strong>oststreptococcal glomerulonephritis (PSGN); <strong>P</strong>olyarteritis nodosa (PAN)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>S-S</strong>ubacute bacterial endocarditis (SABE)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>M- M</strong>alignant hypertension.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 939)</strong></i></span></p>",
    "correct_choice_id": 59892,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14989,
    "choices": [
      {
        "id": 59916,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heavy proteinuria, high cholesterol, high ASO titre </span></span></p>"
      },
      {
        "id": 59917,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heavy proteinuria, hematuria, low ASO titre </span></span></p>"
      },
      {
        "id": 59918,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild proteinuria, hematuria, high ASO titre </span></span></p>"
      },
      {
        "id": 59919,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild proteinuria, high cholesterol, normal ASO titre </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post streptococcal glomerulonephritis in children is diagnosed by: </span></span></p>",
    "unique_key": "Q7371402",
    "question_audio": null,
    "question_video": null,
    "map_id": 32092,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Mild proteinuria, hematuria, high ASO titre </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Post-streptococcal glomerulonephritis (PSGN) </strong>typically occurs after a<strong> streptococcal infection </strong>(such as <strong>strep throat or impetigo</strong>).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features of <strong>PSGN </strong>include <strong>mild proteinuria, hematuria, and elevated antistreptolysin O (ASO) titers.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Heavy proteinuria </strong>is<strong> more </strong>characteristic of <strong>nephrotic syndrome</strong>, which is not the typical presentation of PSGN.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Elevated cholesterol </strong>levels are<strong> more </strong>associated with<strong> nephrotic syndrome </strong>rather than PSGN.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features of<strong> </strong></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Post streptococcal glomerulonephritis </strong>in <strong>children</strong></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> </strong>include <strong>mild proteinuria, hematuria, and elevated antistreptolysin O (ASO) titers</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 906) </span></span></em></strong></p>",
    "correct_choice_id": 59918,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14991,
    "choices": [
      {
        "id": 59924,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
      },
      {
        "id": 59925,
        "text": "<p><span style=\"font-size:12.0pt;\">Hematuria</span></p>"
      },
      {
        "id": 59926,
        "text": "<p><span style=\"font-size:12.0pt;\">Nephritic syndrome</span></p>"
      },
      {
        "id": 59927,
        "text": "<p><span style=\"font-size:12.0pt;\">Renal biopsy having thin basement membrane</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">IgA nephropathy is characterized by all of the following except:</span></p>",
    "unique_key": "Q8779975",
    "question_audio": null,
    "question_video": null,
    "map_id": 32093,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Renal biopsy having thin basement membrane</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A<strong> thin basement membrane </strong>is <strong>not</strong> characteristic of <strong>IgA nephropathy;</strong> this finding is more commonly associated with<strong> thin basement membrane disease</strong>, which is a different condition.<strong> IgA nephropathy </strong>is characterized by<strong> mesangial cell proliferation and mesangial deposits of IgA immune complexes.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong> <strong>Hypertension </strong>can occur in<strong> IgA nephropathy </strong>due to ongoing<strong> kidney damage </strong>and is a common symptom associated with many <strong>chronic kidney diseases</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>Hematuria, </strong>or blood in the urine, is a <strong>hallmark of IgA nephropathy. </strong>It can be recurrent and is often noticed following an <strong>upper respiratory tract infection</strong>, due to the<strong> mesangial deposition </strong>of<strong> IgA immune complexes.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>IgA nephropathy </strong>can present with features of <strong>nephritic syndrome</strong>, which includes <strong>hematuria, </strong>variable degrees of <strong>proteinuria</strong>, and sometimes reduced <strong>kidney function</strong>. It<strong> does not </strong>typically present as <strong>full-blown nephrotic syndrome</strong>, which is characterized by<strong> severe proteinuria, hypoalbuminemia, edema, and hyperlipidemia</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>IgA nephropathy, or Berger's disease</strong>, is identified by the presence of<strong> IgA deposits </strong>within the <strong>glomerular mesangium</strong>, which can lead to symptoms such as<strong> hematuria and hypertension. </strong>A <strong>thin basement membrane </strong>is<strong> not a feature </strong>of this condition and is typically observed in a separate condition known as<strong> thin basement membrane disease</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 922)</strong></i></span></p>",
    "correct_choice_id": 59927,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14992,
    "choices": [
      {
        "id": 59928,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100-150 mg/d </span></span></p>"
      },
      {
        "id": 59929,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">151-200 mg/d </span></span></p>"
      },
      {
        "id": 59930,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">30-300 mg/d </span></span></p>"
      },
      {
        "id": 59931,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">301-600 mg/d </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microalbuminuria is defined as protein levels of:</span></span></span></p>",
    "unique_key": "Q5618699",
    "question_audio": null,
    "question_video": null,
    "map_id": 32094,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 30-300 mg/d</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Microalbuminuria </strong>refers to the excretion of a<strong> moderately increased </strong>amount of <strong>albumin in the urine</strong>. The<strong> normal urinary albumin excretion </strong>rate is<strong> less than 30 mg/day.</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Microalbuminuria </strong>is often defined as a<strong> urinary albumin excretion rate of 30-300 mg/day. </strong>It is an <strong>early sign of kidney damage </strong>and is commonly associated with conditions such as<strong> diabetes and hypertension.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Microalbuminuria </strong>is defined as protein levels of <strong>30-300 mg/day.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 923)</span></em></strong></span></span></p>",
    "correct_choice_id": 59930,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14993,
    "choices": [
      {
        "id": 59932,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SLE</span></span></p>"
      },
      {
        "id": 59933,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persistent hepatitis C infections </span></span></p>"
      },
      {
        "id": 59934,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial lipodystrophy </span></span></p>"
      },
      {
        "id": 59935,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neoplastic diseases </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I membranoproliferative glomerulonephritis is commonly associated with all except: </span></span></span></p>",
    "unique_key": "Q7697747",
    "question_audio": null,
    "question_video": null,
    "map_id": 32095,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Partial lipodystrophy </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial lipodystrophy&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is associated with <strong><em>C3 nephritic factor</em></strong><em> (C3NeF). </em>It is </span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a<strong> rare disorder </strong>characterized by selective <strong>loss of adipose tissue</strong>. It has been reported as an association with<strong> Type II MPGN </strong>and <strong>not type I MPGN.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Type I membranoproliferative glomerulonephritis (MPGN) </strong>can be associated with<strong> SLE </strong>as it is associated with <strong>immune complex-mediated glomerulonephritis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Type I MPGN </strong>has a strong association with <strong>chronic infections</strong>, particularly persistent<strong> hepatitis C infections</strong>. The <strong>immune complexes </strong>formed during <strong>chronic infections </strong>can deposit in the<strong> glomeruli, leading to MPGN.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type I MPGN </strong>has been associated with various <strong>neoplastic diseases</strong>, including <strong>hematological malignancies. </strong>The presence of malignancies can contribute to the formation of<strong> immune complexes</strong>, leading to <strong>glomerular deposition.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type I MPGN </strong>is linked with conditions like <strong>systemic lupus erythematosus (SLE), </strong>chronic infections such as<strong> persistent hepatitis C</strong>, and certain<strong> neoplastic diseases </strong>due to the formation of<strong> immune complexes </strong>and their<strong> deposition in the kidneys</strong>. In contrast,<strong> partial lipodystrophy, </strong>a disorder characterized by the<strong> loss of adipose tissue</strong>, is commonly associated with <strong>Type II MPGN </strong>due to the presence of<strong> C3 nephritic factor (C3NeF), </strong>which <strong>stabilizes </strong>the <strong>alternative pathway C3 </strong>convertase leading to persistent activation of the<strong> complement system</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 918)</span></em></strong></span></span></p>",
    "correct_choice_id": 59934,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15000,
    "choices": [
      {
        "id": 59960,
        "text": "<p><span style=\"font-size:12.0pt;\">Amyloidosis</span></p>"
      },
      {
        "id": 59961,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Diabetes mellitus</span></p>"
      },
      {
        "id": 59962,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Polycystic kidney disease</span></p>"
      },
      {
        "id": 59963,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Benign nephrosclerosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In which of the following conditions bilateral contracted kidneys are characteristically seen?</span></p>",
    "unique_key": "Q8936249",
    "question_audio": null,
    "question_video": null,
    "map_id": 32097,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. D) Benign Nephrosclerosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Benign nephrosclerosis</strong> is associated with <strong>long-standing hypertension </strong>and is characterized by <strong>symmetrically contracted kidneys</strong>. This is a result of <strong>chronic, benign vascular changes </strong>in the kidneys due to<strong> hypertension.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A:</strong> <strong>Amyloidosis </strong>is a condition characterized by the <strong>deposition of abnormal proteins (amyloid) </strong>in various organs, including the <strong>kidneys</strong>. It can lead to <strong>enlarged, pale kidneys </strong>rather than<strong> contracted ones</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B: Chronic diabetes </strong>can lead to <strong>diabetic nephropathy</strong>, which is associated with<strong> diffuse glomerulosclerosis</strong>. In the early stages,<strong> kidneys </strong>may be<strong> enlarged</strong>, but they typically <strong>do not show bilateral contraction.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C: Polycystic kidney disease:</strong> Characterised by enlarged kidney</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Direct quote from Robbins\u2026\u2026</strong>\u2018In<strong> benign nephrosclerosis</strong>, kidneys are either <strong>normal or moderately reduced in size </strong>on gross appearance. The<strong> loss of mass </strong>is due mainly to<strong> cortical scarring and shrinking</strong>\u2019.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 935)</strong></span></p>",
    "correct_choice_id": 59963,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14667,
    "choices": [
      {
        "id": 58629,
        "text": "<p><span style=\"font-size:12pt;\">Polyarteritis nodosa</span></p>"
      },
      {
        "id": 58630,
        "text": "<p><span style=\"font-size:12pt;\">Systemic hypertension</span></p>"
      },
      {
        "id": 58631,
        "text": "<p><span style=\"font-size:12pt;\">Malignant hypertension</span></p>"
      },
      {
        "id": 58632,
        "text": "<p><span style=\"font-size:12pt;\">Wegeners disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 65-year-old woman complains of increased fatigue since last 2 years. Her serum creatinine and blood urea nitrogen are raised. USG shows both kidneys symmetrically reduced in size. Kidney biopsy done shows the following finding. What is the likely diagnosis?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3qbCYsK.png\" width=\"557\" height=\"372\"></p>",
    "unique_key": "Q8190525",
    "question_audio": null,
    "question_video": null,
    "map_id": 32098,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Systemic hypertension</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">This is <strong>hyaline arteriosclerosis</strong> of vessel wall seen in <strong>benign hypertension</strong> wherein the <strong>kidneys are symmetrically contracted</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Similar changes can also be seen in <strong>diabetes mellitus.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>systemic hypertension, </strong>especially <strong>long-standing and poorly controlled cases</strong>, <strong>hyaline arteriosclerosis of the vessel wall </strong>can occur, leading to symmetrically<strong> reduced kidney size</strong>. This finding is consistent with the<strong> patient\u2019s presentation and biopsy </strong>results.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;Polyarteritis nodosa </strong>typically presents with <strong>vasculitis and fibrinoid necrosis </strong>on kidney biopsy. It is characterized by <strong>segmental necrotizing inflammation of medium-sized arteries, </strong>which would be evident on histological examination.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Malignant hypertension </strong>typically presents with <strong>\"flea-bitten\" kidneys </strong>on imaging and demonstrates<strong> fibrinoid necrosis </strong>on kidney biopsy. This <strong>patient's presentation, including symmetrically reduced kidney size and the absence of fibrinoid necrosis</strong>, is not consistent with malignant hypertension.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Wegener's granulomatosis </strong>is characterized by<strong> granulomatous </strong>inflammation of the vessel wall. However, the histological findings described in the<strong> patient's kidney biopsy do not align with this diagnosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Symmetrically reduced kidney size </strong>with<strong> hyaline arteriosclerosis </strong>of the vessel wall is indicative of <strong>systemic hypertension.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Onion-skinning of blood vessels in kidney is seen in:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Malignant hypertension</span></li><li><span style=\"font-size:16px;\">Chronic transplant rejection</span></li><li><span style=\"font-size:16px;\">Thrombotic microangiopathies (e.g., HUS, TTP)</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ p492)</strong></span></p>",
    "correct_choice_id": 58630,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 14970,
    "choices": [
      {
        "id": 59840,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post streptococcal glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 59841,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangiocapillary glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 59842,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cryoglobulinemia </span></span></p>"
      },
      {
        "id": 59843,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SLE</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persistent low C3 complement level is not found in:</span></span></span></p>",
    "unique_key": "Q5441327",
    "question_audio": null,
    "question_video": null,
    "map_id": 32121,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Poststreptococcal glomerulonephritis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Poststreptococcal Glomerulonephritis -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Although associated with <strong>transient hypocomplementemia</strong>, poststreptococcal glomerulonephritis <strong>does not </strong>typically present with <strong>persistent low levels of C3.</strong> C3 levels generally<strong> return to normal </strong>within several <strong>weeks after onset.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Mesangiocapillary Glomerulonephritis -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Persistent low C3 levels </strong>are commonly found in this condition due to continuous <strong>activation of the complement pathway</strong>, making it an important diagnostic marker.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Cryoglobulinemia -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This condition involves the formation of <strong>immune complexes </strong>that can<strong> consume complement proteins</strong>, leading to <strong>persistently low levels of C3.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: SLE -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Systemic lupus erythematosus, an <strong>autoimmune disease</strong>, often involves the formation of <strong>immune complexes </strong>and is typically associated with a<strong> persistent decrease </strong>in <strong>complement proteins</strong>, including<strong> C3</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Poststreptococcal glomerulonephritis </strong>typically exhibits a transient <strong>drop in C3 </strong>levels that resolves with the<strong> acute phase</strong>, while conditions like<strong> mesangiocapillary glomerulonephritis, cryoglobulinemia, and SLE </strong>can show <strong>sustained low </strong>levels indicative of ongoing <strong>immune complex activity and complement activation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 906)</span></span></em></strong></p>",
    "correct_choice_id": 59840,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14996,
    "choices": [
      {
        "id": 59944,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isomorphic RBCs</span></span></p>"
      },
      {
        "id": 59945,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RBC casts </span></span></p>"
      },
      {
        "id": 59946,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nephrotic range proteinuria </span></span></p>"
      },
      {
        "id": 59947,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eosinophiluria </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urine analysis of a patient with haematuria and hypercalciuria is most likely to reveal which of the following?</span></span></span></p>",
    "unique_key": "Q4229922",
    "question_audio": null,
    "question_video": null,
    "map_id": 32096,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Isomorphic RBC </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Isomorphic RBCs </strong>in the <strong>urine </strong>refer to the presence of intact <strong>red blood cells </strong>without any significant changes in <strong>shape or size</strong>. The presence of <strong>isomorphic RBCs </strong>in urine suggests <strong>bleeding from a non glomerular </strong>cause in the<strong> kidney or the lower urinary tract</strong>, such as the<strong> bladder or urethra</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence o<strong>f RBC casts in urine </strong>indicates <strong>glomerular bleeding. </strong>Glomerular bleeding can occur in conditions such as <strong>glomerulonephritis or vasculitis</strong>. The formation of<strong> casts occurs within the renal tubules </strong>and is a characteristic finding in <strong>glomerular diseases.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nephrotic range proteinuria </strong>refers to the<strong> excessive </strong>loss of <strong>protein in the urine</strong>, typically exceeding<strong> 3.5 grams per day</strong>. This condition is often associated with <strong>glomerular diseases</strong>, such as<strong> membranous nephropathy or minimal change disease. </strong>It may present with features like <strong>edema, hypoalbuminemia, and hyperlipidemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Eosinophiluria </strong>refers to the <strong>presence of eosinophils </strong>in the urine. It can be associated with <strong>allergic reactions, interstitial nephritis, or certain parasitic infections. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To <strong>diagnose </strong>the cause of <strong>hematuria </strong>in patients presenting with <strong>haematuria and hypercalciuria</strong>, it is crucial to examine the <strong>morphology of red blood cells (RBCs) </strong>in the urine.The presence of<strong> isomorphic RBCs </strong>implies <strong>bleeding </strong>from areas like the<strong> renal calyces, pelvis, ureter, bladder, or urethra</strong>, where the <strong>RBCs do not </strong>undergo significant <strong>alterations in shape. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Paediatric Nephrology 5<sup>th</sup> /141, 190 by Dr R.N. Srivas&shy;tava and Dr Arvind Bagga)</span></span></em></strong></p>",
    "correct_choice_id": 59944,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14952,
    "choices": [
      {
        "id": 59768,
        "text": "<p><span style=\"font-size:12pt;\">Tip variant</span></p>"
      },
      {
        "id": 59769,
        "text": "<p><span style=\"font-size:12.0pt;\">Collapsing</span></p>"
      },
      {
        "id": 59770,
        "text": "<p><span style=\"font-size:12.0pt;\">NOS</span></p>"
      },
      {
        "id": 59771,
        "text": "<p><span style=\"font-size:12.0pt;\">Perihilar</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 35-year-old man with a history of intravenous drug abuse presents with worsening kidney function. Renal biopsy reveals collapsing variant of focal segmental glomerulosclerosis (FSGS). Which of the following features is characteristic of this variant and is associated with a worse prognosis?</span></p>",
    "unique_key": "Q9552649",
    "question_audio": null,
    "question_video": null,
    "map_id": 32115,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Collapsing</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>collapsing variant </strong>is characterized by the<strong> collapse of glomerular capillaries </strong>and <strong>overt tuft collapse</strong>, which leads to <strong>rapid progression of renal disease </strong>and a<strong> poorer prognosis, </strong>making this the correct answer.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Five mutually exclusive variants of<strong> focal seg\u00admental glomerulosclerosis (FSGS) </strong>may be <strong>dis\u00adtinguished </strong>by the<strong> pathological findings </strong>seen on<strong> renal biopsy</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Collapsing variant</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Glomerular tip lesion variant</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Cellular variant</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Perihilar variant</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Not otherwise specified variant (NOS)</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;</strong>The tip variant of <strong>FSGS </strong>affects the segment of the glomerulus <strong>near the proximal tubule </strong>and is associated with <strong>better outcomes compared </strong>to <strong>other variants</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>NOS (not otherwise specified) </strong>variant is the<strong> most common type of FSGS </strong>and has a <strong>variable prognosis </strong>that is generally <strong>not as poor as </strong>the <strong>collapsing variant</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> The <strong>perihilar variant </strong>of <strong>FSGS </strong>has<strong> sclerotic lesions </strong>predominantly at the <strong>vascular pole of the glomerulus </strong>and <strong>does not </strong>typically <strong>progress as rapidly as </strong>the<strong> collapsing variant</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>NOS variant is the most common </strong>subtype and <strong>collapsing FSGS has worst prognosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbin\u2019s 10<sup>th</sup>/ 916)</strong></span></p>",
    "correct_choice_id": 59769,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 14949,
    "choices": [
      {
        "id": 59756,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minimal change disease </span></span></span></p>"
      },
      {
        "id": 59757,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rapidly progressive glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 59758,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Focal and segmental glomerulosclerosis </span></span></span></p>"
      },
      {
        "id": 59759,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rapidly non progressive glomerulonephritis </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crescent formation is characteristic of which of the following glomerular disease?</span></span></span></p>",
    "unique_key": "Q2134264",
    "question_audio": null,
    "question_video": null,
    "map_id": 32112,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Rapidly progressive glomerulonephritis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rapidly progressive glomerulonephritis </strong>is indeed associated with <strong>crescent formation</strong>, which can be seen in most of the<strong> glomeruli</strong>. This type of<strong> glomerulonephritis </strong>progresses <strong>quickly</strong>, often leading to<strong> renal failure </strong>in a <strong>short period of time.</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rapidly progressive glomerulonephritis</strong>, also known as<strong> crescentic glomerulonephritis </strong>is charac&shy;terized by the <strong>presence of crescents </strong>in most of the glomeruli. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Crescents </strong>are produced by proliferation of the <strong><em>pari&shy;etal epithelial cells of Bowman&rsquo;s capsule and by infiltration of monocytes and macrophages</em></strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Minimal change disease </strong>typically presents with <strong>nephrotic syndrome </strong>and is characterized by <strong>minimal changes </strong>on <strong>light microscopy</strong>; specifically, it<strong> lacks inflammatory changes or crescents.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Focal and segmental glomerulosclerosis </strong>involves <strong>scarring in specific areas of the glomeruli</strong>. It is not primarily associated with crescent formation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The term <strong>&#39;rapidly non-progressive glomerulonephritis&#39; </strong>is not commonly used. However, any <strong>non-progressive form of glomerulonephritis </strong>would<strong> not </strong>typically feature<strong> crescent formation</strong>, which is indicative of a <strong>more aggressive disease process</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rapidly progressive glomerulonephritis </strong>is characterized by the <strong>formation of crescents</strong>, which are structures formed by the <strong>proliferation of parietal epithelial cells of Bowman&rsquo;s capsule </strong>and <strong>infiltration of monocytes and macrophages</strong>. This condition requires prompt <strong>diagnosis and treatment </strong>due to its <strong>rapid progression </strong>and potential to quickly lead to<strong> irreversible renal damage</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 909)</span></span></em></strong></p>",
    "correct_choice_id": 59757,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14953,
    "choices": [
      {
        "id": 59772,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuft necrosis </span></span></span></p>"
      },
      {
        "id": 59773,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangiolysis </span></span></p>"
      },
      {
        "id": 59774,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parietal epithelial proliferation </span></span></span></p>"
      },
      {
        "id": 59775,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertrophy and necrosis of visceral epithelium </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a feature of collapsing glomerulopathy?</span></span></span></p>",
    "unique_key": "Q3124170",
    "question_audio": null,
    "question_video": null,
    "map_id": 32116,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Hypertrophy and necrosis of visceral epithe&shy;lium</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Collapsing glomerulopathy </strong>is a <strong>distinct </strong>pattern of <strong>glomerular injury </strong>characterized by <strong>hypertrophy and necrosis of visceral epithelial cells (podocytes). </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tuft necrosis </strong>refers to the <strong>destruction of the glomerular tuft</strong>, and this is <strong>not </strong>a characteristic feature of <strong>collapsing glomerulopathy</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mesangiolysis </strong>involves <strong>disruption of mesangial cells and matrix</strong>, but it is <strong>not </strong>a prominent feature of <strong>collapsing glomerulopathy</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Parietal epithelial proliferation </strong>is<strong> not </strong>a typical finding in <strong>collapsing glomerulopathy</strong>; instead, the <strong>pathology </strong>primarily involves changes in the<strong> visceral epithelial cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hypertrophy and necrosis of visceral epithelium </strong>is a distinctive feature of <strong>collapsing glomerulopathy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref. Robbin&rsquo;s 10<sup>th</sup>/ 917)</span></span></em></strong></p>",
    "correct_choice_id": 59775,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14985,
    "choices": [
      {
        "id": 59900,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Berger disease </span></span></span></p>"
      },
      {
        "id": 59901,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Focal segmental glomerulosclerosis </span></span></span></p>"
      },
      {
        "id": 59902,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Membranous glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 59903,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minimal change disease </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common cause of nephritic syndrome in adults is: </span></span></span></p>",
    "unique_key": "Q4673805",
    "question_audio": null,
    "question_video": null,
    "map_id": 32091,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Berger disease </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgA nephropathy</strong>, also known as <strong>Berger&#39;s disease</strong>, is a common cause of <strong>nephritic syndrome </strong>in adults. It is characterized by the deposition of<strong> IgA immune complexes </strong>in the<strong> glomeruli, </strong>leading to <strong>inflammation and damage</strong>. This condition often presents with <strong>recurrent episodes of gross hematuria</strong>, usually following <strong>upper respiratory tract infections</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Focal segmental glomerulosclerosis </strong>is<strong> more commonly </strong>associated with <strong>nephrotic syndrome </strong>than nephritic syndrome. It involves <strong>scarring of some glomeruli</strong>, leading to<strong> proteinuria</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Membranous glomerulonephritis </strong>is also more commonly associated with<strong> nephrotic syndrome</strong>. It involves <strong>thickening </strong>of the<strong> glomerular basement membrane </strong>and can present with<strong> proteinuria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Minimal change disease </strong>is a common cause of <strong>nephrotic syndrome in children</strong>. It is characterized by <strong>minimal changes on light microscopy </strong>but significant <strong>proteinuria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Most </strong>common cause of<strong> nephritic syndrome in adults is Berger&rsquo;s disease</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 920) </span></span></em></strong></p>",
    "correct_choice_id": 59900,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14931,
    "choices": [
      {
        "id": 59684,
        "text": "<p><span style=\"font-size:12.0pt;\">Autosomal dominant polycystic kidney disease</span></p>"
      },
      {
        "id": 59685,
        "text": "<p><span style=\"font-size:12pt;\">Autosomal recessive polycystic kidney disease</span></p>"
      },
      {
        "id": 59686,
        "text": "<p><span style=\"font-size:12pt;\">Oxalosis&nbsp;<i>&nbsp;</i></span></p>"
      },
      {
        "id": 59687,
        "text": "<p><span style=\"font-size:12pt;\">Alport syndrome</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 28-year-old man has lenticonus and end stage renal disease now. His maternal uncle also died of the same illness. What is the most likely diagnosis?</span></p>",
    "unique_key": "Q7111760",
    "question_audio": null,
    "question_video": null,
    "map_id": 32268,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Alport\u2019s syndrome</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Presentation of <strong>male </strong>patient with<strong> lenticonus and end stage renal disease </strong>with a <strong>family history of renal disease </strong>is highly suggestive of<strong> Alport syndrome</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Autosomal Dominant Polycystic Kidney Disease (ADPKD):&nbsp;</strong>it is a<strong> genetic disorder </strong>characterized by the development of <strong>fluid-filled cysts </strong>in the kidneys. It is an adult-onset condition, and lenticonus (cone-shaped deformity of the lens) is not a typical feature of ADPKD.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Autosomal Recessive Polycystic Kidney Disease (ARPKD): </strong>it is a<strong> rare genetic disorder </strong>that primarily affects the<strong> kidneys and liver</strong>. It often presents in<strong> childhood, </strong>and patients may develop<strong> end-stage renal disease (ESRD) at a young age</strong>.<strong> Lenticonus is not </strong>a characteristic feature of ARPKD.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Oxalosis&nbsp;</strong>is a condition where <strong>excessive oxalate accumulates </strong>in various organs, including the <strong>kidneys. </strong>It can lead to <strong>renal failure</strong>, but<strong> lenticonus is not </strong>a typical manifestation of<strong> oxalosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Alport Syndrome </strong>is a genetic disorder characterized by <strong>progressive kidney disease, hearing loss, and eye abnormalities</strong>. It results from mutations affecting <strong>type IV collagen</strong>, essential for normal function in the<strong> kidneys, inner ear, and eyes.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Genes Involved:</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_BzRH3BE.png\" width=\"1249\" height=\"223\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 922)</strong></span></p>",
    "correct_choice_id": 59687,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 14936,
    "choices": [
      {
        "id": 59704,
        "text": "<p><span style=\"font-size:12pt;\">IgA nephropathy is likely diagnosis</span></p>"
      },
      {
        "id": 59705,
        "text": "<p><span style=\"font-size:12pt;\">Her C3 levels will be low</span></p>"
      },
      {
        "id": 59706,
        "text": "<p><span style=\"font-size:12pt;\">No IgG deposits or C3 deposition on renal biopsy</span></p>"
      },
      {
        "id": 59707,
        "text": "<p><span style=\"font-size:12pt;\">Alport syndrome is likely diagnosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 7 yrs old girl is brought with complaints of generalized swelling of the body. Urinary examination reveals grade 3 proteinuria and the presence of hyaline and fatty casts. She has no history of hematuria. Which of the following statements about her condition is true?</span></p>",
    "unique_key": "Q2123058",
    "question_audio": null,
    "question_video": null,
    "map_id": 32272,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) No IgG deposits or C3 deposition on renal biopsy</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In<strong> minimal change disease (MCD), </strong>the most common cause of <strong>nephrotic syndrome in children</strong>, renal biopsies <strong>do not show IgG deposits or C3 deposition. </strong>MCD is characterized by the <strong>effacement of podocyte foot processes </strong>and is often <strong>responsive to corticosteroids</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The clinical symptoms and the findings in the stem of the question<strong> (child with generalized swelling because of reduced serum protein </strong>secondary to <strong>massive proteinuria with urinary lipid casts</strong>) are suggestive of<strong> nephrotic syndrome</strong>. The commonest cause in a child of<strong> nephrotic syndrome is lipoid nephrosis or minimal change disease</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong>&nbsp;<strong>IgA nephropathy </strong>is a common cause of <strong>glomerulonephritis </strong>that often presents with <strong>hematuria </strong>following an<strong> upper respiratory tract infection</strong>, making it less likely in this case without a history of hematuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;Low C3 levels </strong>are typically associated with<strong> complement-mediated conditions </strong>such as<strong> post-infectious glomerulonephritis or membranoproliferative glomerulonephritis</strong>, not typically seen in minimal change disease.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong>&nbsp;<strong>Alport syndrome </strong>is characterized by<strong> hematuria, progressive renal failure, and hearing loss</strong>, and is caused by <strong>genetic mutations </strong>affecting <strong>type IV collagen</strong>; it is <strong>not </strong>the most likely diagnosis given the <strong>absence of hematuria </strong>and the patient's presentation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The most likely diagnosis for a<strong> child presenting </strong>with<strong> nephrotic syndrome and no hematuria</strong>, evidenced by <strong>proteinuria and lipiduria, is minimal change disease</strong>. This condition <strong>does not show IgG deposits or C3 deposition on renal biopsy</strong>, and <strong>electron microscopy would </strong>reveal <strong>effacement of the podocyte foot processes.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbin\u2019s 10<sup>th</sup>/ 914)</strong></i></span></p>",
    "correct_choice_id": 59706,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 14933,
    "choices": [
      {
        "id": 59692,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alport&rsquo;s syndrome </span></span></span></p>"
      },
      {
        "id": 59693,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Good pasture&rsquo;s syndrome </span></span></span></p>"
      },
      {
        "id": 59694,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thin membrane disease </span></span></span></p>"
      },
      {
        "id": 59695,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nodular glomerulosclerosis </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the diagnosis for a condition having mutation in COL4A5 chain?</span></span></span></p>",
    "unique_key": "Q8434616",
    "question_audio": null,
    "question_video": null,
    "map_id": 32269,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Alport&rsquo;s syndrome </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alport&#39;s syndrome </strong>is a <strong>genetic disorder </strong>affecting the<strong> basement membrane of the kidney, ear, and eye</strong>. <strong>Mutations </strong>in genes like <strong>COL4A5 </strong>can lead to <strong>Alport&#39;s syndrome.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Goodpasture&#39;s syndrome </strong>is an <strong>autoimmune disorder </strong>that primarily affects the<strong> lungs and kidneys. </strong>It is characterized by the presence of <strong>autoantibodies </strong>against the <strong>alpha-3 chain of type IV collagen</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Thin Membrane Disease</strong>: It affects <strong>collagen alpha chain type 4</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong> <span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nodular glomerulosclerosis </strong>is a histological pattern seen in<strong> diabetic nephropathy, </strong>where there is <strong>nodular thickening of the glomerular basement membrane. </strong>It is not associated with mutations in COL4A5.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mutations </strong>in genes like<strong> COL4A5 </strong>can lead to<strong> Alport&#39;s syndrome</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 922)</span></em></strong></span></span></p>",
    "correct_choice_id": 59692,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14934,
    "choices": [
      {
        "id": 59696,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACE</span></span></span></p>"
      },
      {
        "id": 59697,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">NPHS 2 </span></span></span></p>"
      },
      {
        "id": 59698,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">HOX11</span></span></span></p>"
      },
      {
        "id": 59699,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">PAX </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common gene defect in idiopathic steroid resistance nephrotic syndrome:</span></span></span></p>",
    "unique_key": "Q7539857",
    "question_audio": null,
    "question_video": null,
    "map_id": 32270,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) NPHS 2 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>NPHS2 </strong>mutations are commonly associated with <strong>autosomal recessive steroid-resistant nephrotic syndrome</strong>. <strong>Podocin </strong>is a protein that plays a crucial role in the <strong>structure and function of the glomerular filtration barrier</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>ACE </strong>is<strong> not </strong>typically associated with <strong>idiopathic steroid-resistant nephrotic syndrome</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> HOX11 (also known as TLX1) </strong>is associated with<strong> T-cell acute lymphoblastic leukemia (T-ALL), </strong>not nephrotic syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>PAX genes </strong>are involved in various<strong> developmental processes </strong>and are<strong> not </strong>specifically associated with <strong>nephrotic syndrome</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/16/picture2_IbeYko6.jpg\" style=\"height:127px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common<strong> gene defect </strong>in<strong> idiopathic steroid resistance nephrotic syndrome </strong>is <strong>NPHS2.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th </sup>915) </span></em></strong></span></span></p>",
    "correct_choice_id": 59697,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14935,
    "choices": [
      {
        "id": 59700,
        "text": "<p><span style=\"font-size:12pt;\">Focal segmental glomerulosclerosis</span></p>"
      },
      {
        "id": 59701,
        "text": "<p><span style=\"font-size:12pt;\">Nodular glomerulosclerosis</span></p>"
      },
      {
        "id": 59702,
        "text": "<p><span style=\"font-size:12pt;\">Membranous glomerulopathy</span></p>"
      },
      {
        "id": 59703,
        "text": "<p><span style=\"font-size:12pt;\">Proliferative glomerulonephritis with crescents</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A person with radiologically confirmed reflux nephropathy develops nephrotic range proteinuria. Which of the following would be the most likely histological finding in this patient?</span></p>",
    "unique_key": "Q1643579",
    "question_audio": null,
    "question_video": null,
    "map_id": 32271,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Focal segmental glomerulosclerosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Reflux nephropathy </strong>is characterized by <strong>chronic inflammation and scarring </strong>due to <strong>vesicoureteral reflux</strong>. Nephrotic range <strong>proteinuria</strong> suggests<strong> glomerular involvement,</strong> and <strong>focal segmental glomerulosclerosis</strong> is a common cause of <strong>nephrotic syndrome.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Direct quote\u2026\u2018<strong>FSGS </strong>occurs as a component of the adaptive response to<strong> loss of renal tissue </strong>in advanced stage of other renal disorders such as <strong>reflux nephropathy, hypertensive nephropathy </strong>and&nbsp; <strong>unilateral renal agenesis</strong>.\u2019</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Membranous glomerulopathy </strong>is characterized by the<strong> thickening of the glomerular basement membrane, </strong>often forming <strong>immune complexes</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>Nodular glomerulosclerosis </strong>is <strong>not</strong> a common feature of <strong>reflux nephropathy</strong>. It is<strong> seen with diabetic nephropathy.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D</strong>:<strong> Proliferative glomerulonephritis </strong>with <strong>crescents </strong>is more associated with <strong>nephritic range proteinuria </strong>rather than nephrotic range.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective</u></strong><u>:</u></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Reflux nephropathy </strong>and <strong>nephrotic range proteinuria </strong>are commonly seen in <strong>Focal segmental glomerulosclerosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref Robbins 10<sup>th</sup>/ 915)</strong></span></p>",
    "correct_choice_id": 59700,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14972,
    "choices": [
      {
        "id": 59848,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetic Nephropathy </span></span></span></p>"
      },
      {
        "id": 59849,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Analgesic nephropathy </span></span></span></p>"
      },
      {
        "id": 59850,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RPGN </span></span></p>"
      },
      {
        "id": 59851,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post streptococcal glomerulonephritis </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old woman presents with worsening renal function and proteinuria. Renal biopsy shows nodular glomerulosclerosis with eosinophilic deposits in the mesangium and thickening of the glomerular basement membrane. Immunofluorescence staining reveals granular deposits of IgG and C3. The </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kimmelstiel Wilson lesions are characteristic of:</span></span></span></p>",
    "unique_key": "Q3111313",
    "question_audio": null,
    "question_video": null,
    "map_id": 32273,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Diabetic nephropathy </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Kimmelstiel-Wilson lesions,</strong> also known as nodular <strong>glomerulosclerosis</strong>, are a pathognomonic finding in <strong>diabetic nephropathy. </strong>These lesions consist of<strong> nodular deposits of mesangial matrix within the glomerulus. </strong>The KW lesions are associated with <strong>progressive renal damage in the context of diabetes. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Analgesic nephropathy </strong>refers to <strong>kidney damage </strong>caused by the <strong>long-term </strong>use of certain <strong>analgesic medications</strong>, particularly those containing <strong>phenacetin. </strong>It is characterized by <strong>chronic interstitial nephritis</strong>, <strong>papillary necrosis</strong>, and <strong>renal papillary atrophy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>RPGN </strong>is a term used to describe a clinical syndrome characterized by a <strong>rapid decline in renal function</strong>. Various forms of <strong>glomerulonephritis, </strong>including <strong>anti-glomerular basement membrane (anti-GBM) disease and immune complex-mediated glomerulonephritis</strong>, can present as<strong> RPGN</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Post-streptococcal glomerulonephritis (PSGN) </strong>is an<strong> immune complex-mediated glomerulonephritis </strong>that occurs following certain<strong> streptococcal infections</strong>, particularly<strong> streptococcal pharyngitis. </strong>It is characterized by <strong>diffuse proliferative glomerulonephritis </strong>with prominent inflammatory changes.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Kimmelstiel-Wilson lesions</strong>, also known as<strong> nodular glomerulosclerosis, </strong>are a pathognomonic finding in <strong>diabetic nephropathy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbin 10<sup>th</sup>/ 923)</span></em></strong></span></span></p>",
    "correct_choice_id": 59848,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14978,
    "choices": [
      {
        "id": 59872,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in plasma protein concentration </span></span></span></p>"
      },
      {
        "id": 59873,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in plasma protein concentration </span></span></span></p>"
      },
      {
        "id": 59874,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced plasma osmotic pressure </span></span></span></p>"
      },
      {
        "id": 59875,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium and water retention </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The cause of edema in nephritic syndrome is: </span></span></span></p>",
    "unique_key": "Q9594858",
    "question_audio": null,
    "question_video": null,
    "map_id": 32265,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Sodium and water retention </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium and water retention:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the<strong> correct </strong>answer. In <strong>nephritic syndrome</strong>, the primary mechanism for<strong> edema is the retention of sodium and water </strong>due to <strong>reduced glomerular filtration rate </strong>and <strong>altered renal perfusion</strong>, which can be a direct consequence of <strong>glomerular inflammation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sodium and water retention </strong>(option d) the primary cause of<strong> edema formation in nephritic&nbsp;</strong></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>syndrome </strong>but the <strong>loss of plasma proteins </strong>may also contribute to the same.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Decrease in plasma protein concentration</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While a<strong> decrease in plasma proteins </strong>can contribute to edema through <strong>reduced colloid osmotic pressure</strong>, it is <strong>more characteristic of nephrotic </strong>rather than nephritic syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Increase in plasma protein concentration: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option is<strong> incorrect</strong>, as <strong>nephritic syndrome does not </strong>typically involve an <strong>increase in plasma protein concentration.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Reduced plasma osmotic pressure:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This could <strong>theoretically </strong>contribute to <strong>edema</strong>; however, in the context of<strong> nephritic syndrome</strong>, it is <strong>not the primary cause.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>In nephritic syndrome</strong>, <strong>edema </strong>is primarily caused by<strong> sodium and water retention </strong>due to the <strong>body&#39;s response to kidney inflammation and injury </strong>is essential for<strong> guiding </strong>appropriate<strong> treatment strategies. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 906) </span></span></em></strong> </span></span></span></em></strong></p>",
    "correct_choice_id": 59875,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 14979,
    "choices": [
      {
        "id": 59876,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombocytopenia with renal failure </span></span></span></p>"
      },
      {
        "id": 59877,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal coagulative profile </span></span></span></p>"
      },
      {
        "id": 59878,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microangiopathic hemolytic anemia </span></span></span></p>"
      },
      {
        "id": 59879,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old child presents to the emergency department with bloody diarrhea, abdominal pain, and decreased urine output. Physical examination reveals pallor and petechiae. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In hemolytic uremic syndrome there is:</span></span></span></p>",
    "unique_key": "Q3875502",
    "question_audio": null,
    "question_video": null,
    "map_id": 32266,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All of the above </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Thrombocytopenia with renal failure:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Thrombocytopenia is a <strong>hallmark feature of hemolytic uremic syndrome (HUS), </strong>resulting from the <strong>formation of microthrombi in small blood vessels</strong>. <strong>Renal failure </strong>is a common complication due to the <strong>microvascular thrombosis </strong>affecting the <strong>kidneys.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Normal coagulative profile:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In HUS, the coagulative profile is<strong> normal.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Microangiopathic hemolytic anemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> MAHA is a characteristic<strong> feature of HUS. </strong>It results from the<strong> fragmentation of red blood cells </strong>as they <strong>traverse </strong>through <strong>damaged small blood vessels</strong>, leading to<strong> schistocytes or fragmented red blood cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>classic triad </strong>of hemolytic uremic syndrome <strong>(HUS),&nbsp; </strong>includes <strong>thrombocytopenia </strong>with<strong> renal failure due to microthrombi, </strong>a <strong>normal coagulative profile&nbsp;</strong></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">distinguishing it from<strong> disseminated intravascular coagulation (DIC), </strong>and<strong> micro-angiopathic&nbsp;</strong></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>hemolytic anemia (MAHA) </strong>characterized by<strong> hemolysis of red blood cells due to vascular&nbsp;</strong></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>injury</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 938) </span></span></em></strong> </span></span></span></em></strong></p>",
    "correct_choice_id": 59879,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14980,
    "choices": [
      {
        "id": 59880,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Membranous nephropathy</span></p>"
      },
      {
        "id": 59881,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Membranoproliferative glomerulonephritis</span></p>"
      },
      {
        "id": 59882,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">IgA nephropathy</span></p>"
      },
      {
        "id": 59883,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Crescentic glomerulonephritis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Tram track appearance on histopathology of kidney is seen in:</span></p>",
    "unique_key": "Q4884620",
    "question_audio": null,
    "question_video": null,
    "map_id": 32267,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Membranoproliferative glomerulonephritis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Membranoproliferative glomerulonephritis</strong> involves <strong>both mesangial and subendothelial immune complex deposits</strong>. It typically presents with a<strong> lobular appearance </strong>on histopathology and a <strong>\u201ctram track appearance\u201d.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A: Membranous nephropathy</strong> is characterized by the <strong>presence of subepithelial immune complex deposits</strong>, leading to a characteristic <strong>spike and dome appearance </strong>on histopathology.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: IgA nephropathy</strong> is characterized by the <strong>deposition of IgA immune complexes </strong>in the <strong>mesangium of the glomeruli</strong>. It usually <strong>does not </strong>present with <strong>tram track appearance</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Crescentic glomerulonephritis</strong> is associated with the formation of<strong> crescents in Bowman's space </strong>due to<strong> severe inflammation and glomerular injury</strong>. It does not typically present with tram track appearance.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture1.jpg\" alt=\"\" width=\"1000\" height=\"262\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 917)</strong></i></span></p>",
    "correct_choice_id": 59881,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14976,
    "choices": [
      {
        "id": 59864,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Goodpasture&rsquo;s syndrome </span></span></span></p>"
      },
      {
        "id": 59865,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Berger disease </span></span></span></p>"
      },
      {
        "id": 59866,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crescentic glomerulonephritis </span></span></span></p>"
      },
      {
        "id": 59867,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alport syndrome </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgA depositions in mesangial cells are seen in?</span></span></span></p>",
    "unique_key": "Q2743676",
    "question_audio": null,
    "question_video": null,
    "map_id": 32264,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Berger disease<em> </em></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Berger Disease (IgA Nephropathy):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the correct answer. It is defined by the deposition of<strong> IgA immune complexes </strong>within the <strong>mesangium of the glomeruli, </strong>seen as<strong> mesangial proliferation and IgA deposits </strong>on immunofluorescence.</span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgA nephropathy</strong>, also known as <strong>Berger disease</strong>, is characterized by the <strong>deposition of IgA immune complexes </strong>in the <strong>mesangial area of the glomerulus.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Goodpasture&rsquo;s Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterized by <strong>anti-GBM antibodies </strong>leading to <strong>linear immunofluorescence</strong>. Goodpasture&#39;s <strong>does not </strong>feature<strong> IgA </strong>deposition but instead has<strong> antibodies against the glomerular </strong>and <strong>alveolar basement membranes</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Crescentic Glomerulonephritis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This refers to a severe form of <strong>glomerulonephritis </strong>marked by <strong>crescent formation</strong>. While it can be due to <strong>IgA nephropathy</strong>, it can also arise from other causes and <strong>does not </strong>specifically imply <strong>IgA deposition.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Alport Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A<strong> hereditary disorder </strong>caused by <strong>mutations in genes </strong>encoding <strong>type IV collagen, </strong>leading to<strong> glomerular basement membrane </strong>abnormalities. It<strong> does not </strong>involve<strong> IgA deposits</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of <strong>mesangial IgA immune complexes </strong>is pathognomonic for<strong> Berger&#39;s disease</strong>, also known as<strong> IgA nephropathy</strong>. In contrast, <strong>Goodpasture&rsquo;s syndrome </strong>involves <strong>anti-GBM antibodies,</strong> crescentic glomerulonephritis may or may<strong> not involve IgA </strong>depending on the underlying cause, and <strong>Alport syndrome </strong>is a genetic condition with a distinct pathophysiology<strong> not involving IgA</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 920)</span></span></em></strong></p>",
    "correct_choice_id": 59865,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14973,
    "choices": [
      {
        "id": 59852,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal C3 </span></span></p>"
      },
      {
        "id": 59853,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertension</span></span></p>"
      },
      {
        "id": 59854,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated blood urea and creatinine </span></span></p>"
      },
      {
        "id": 59855,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased ASO titre </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following is not a feature of acute post streptococcal glomerulonephritis:</span></span></span></p>",
    "unique_key": "Q3569409",
    "question_audio": null,
    "question_video": null,
    "map_id": 32274,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Normal C3 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acute poststreptococcal glomerulonephritis (APSGN) </strong>is characterized by the deposition of<strong> immune complexes</strong> in the glomeruli, leading to<strong> inflammation. </strong>Typically it is associated with <strong>decreased levels of serum complement,</strong> including <strong>C3. </strong>Therefore, having a <strong>normal C3 level </strong>would be unusual in the context of<strong> APSGN.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Hypertension </strong>is a common feature of<strong> acute poststreptococcal glomerulonephritis. </strong>The mechanism involves <strong>increased fluid retention</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> APSGN </strong>can lead to a<strong> rise in blood urea and creatinine levels </strong>due to<strong> impaired renal function </strong>caused by <strong>glomerular inflammation</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Streptococcal infections, </strong>particularly <strong>group A streptococcus, </strong>can lead to the production of <strong>anti-streptolysin O (ASO) antibodies. Elevated ASO titres </strong>are a characteristic feature of<strong> streptococcal infections </strong>and are often used to support the diagnosis of <strong>recent streptococcal infections</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:&nbsp; </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acute post-streptococcal glomerulonephritis (PSGN) </strong>is associated with <strong>decreased levels of serum complement</strong>, including <strong>C3.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 906) </span></span></em></strong></p>",
    "correct_choice_id": 59852,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14974,
    "choices": [
      {
        "id": 59856,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crescents in most of the glomeruli </span></span></p>"
      },
      {
        "id": 59857,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loss of foot processes of epithelial cells </span></span></p>"
      },
      {
        "id": 59858,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subendothelial electron dense deposits </span></span></p>"
      },
      {
        "id": 59859,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The thickening of glomerular capillary wall</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histological hallmark of rapidly progressive glomerulonephritis is?</span></span></span></p>",
    "unique_key": "Q4620202",
    "question_audio": null,
    "question_video": null,
    "map_id": 32275,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Crescents in most of glomeruli </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rapidly progressive glomerulonephritis (RPGN) </strong>is characterized by the<strong> presence of crescents </strong>in most of the <strong>glomeruli</strong>. Crescents result from the accumulation of<strong> proliferating parietal epithelial cells, macrophages, and fibrin within Bowman&#39;s space.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Loss of foot processes </strong>can lead to <strong>proteinuria&nbsp; </strong>and is a histological finding of<strong> minimal change disease </strong>and <strong>focal segmental glomerulosclerosis </strong>rather than <strong>RPGN.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Subendothelial electron dense </strong>deposits are associated with conditions like <strong>MPGN&nbsp; </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Thickening of the glomerular capillary wall </strong>is a characteristic finding in conditions like <strong>diabetic nephropathy and membranous nephropathy</strong>. It is<strong> not </strong>a specific feature of<strong> RPGN.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Histological hallmark </strong>of <strong>rapidly progressive glomerulonephritis is crescents </strong>in most of the <strong>glomeruli.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 909)</span></span></em></strong></p>",
    "correct_choice_id": 59856,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 13636,
    "choices": [
      {
        "id": 54505,
        "text": "<p><span style=\"font-size:16px;\">Reduced rate of proliferation</span></p>"
      },
      {
        "id": 54506,
        "text": "<p><span style=\"font-size:16px;\">Absence of metastasis</span></p>"
      },
      {
        "id": 54507,
        "text": "<p><span style=\"font-size:16px;\">Anaplasia</span></p>"
      },
      {
        "id": 54508,
        "text": "<p><span style=\"font-size:16px;\">Sparing of basement membrane</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A 4-year-old boy is evaluated by his pediatrician for 1 week of intermittent hematuria. On examination he appears well developed and well nourished, except a right flank mass is palpable. A biopsy of the mass is performed, which reveals primitive looking small blue cells with glomerular and tubular structures (image). Which of the following indicates poor prognosis for the patient?</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/08/screenshot-2024-02-08-194503.jpg\" alt=\"\" width=\"300\" height=\"202\"></span></p>",
    "unique_key": "Q7050545",
    "question_audio": null,
    "question_video": null,
    "map_id": 32292,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Anaplasia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical features and history points towards</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The most common renal malignancy in children is Wilms tumor, usually presented with a palpable mass or hematuria. This tumor, most often caused by a mutation of the WT1 tumor suppressor gene (chromosome 11p13) and is characterized histologically by as a triphasic tumor. The presence of anaplasia is important factor indicating aggressive nature of the tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A:</strong> <strong>Reduced rate of proliferation</strong> actually suggests a better prognosis as it indicates slower tumor growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B:</strong> <strong>Absence of metastasis</strong> is a favorable prognostic factor, not a poor prognostic indicator.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D:</strong> <strong>Sparing of basement membrane&nbsp;</strong>suggests the tumor is less invasive, which is associated with better outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Wilms tumor (nephroblastoma):</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Most common malignant renal tumor of childhood (usually before age 5).</span></li><li><span style=\"font-size:12.0pt;\">Classic presentation: asymptomatic abdominal/flank mass; sometimes hematuria, hypertension, or abdominal pain.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histology: so-called triphasic pattern:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Blastemal component \u2192 small round blue cells</span></li><li><span style=\"font-size:12.0pt;\">Epithelial component \u2192 primitive tubules and glomeruloid structures</span></li><li><span style=\"font-size:12.0pt;\">Stromal component \u2192 fibrous tissue, muscle, cartilage</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What determines prognosis in Wilms tumor?</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Most patients with Wilms tumor do very well today (survival &gt;90%) thanks to surgery and chemotherapy.</span></li><li><span style=\"font-size:12.0pt;\">But there are certain factors that predict worse prognosis:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Anaplasia (unfavorable histology) \u2192 the single most important adverse prognostic feature.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Markedly enlarged, pleomorphic (very variable in size and shape) hyperchromatic nuclei</span></li><li><span style=\"font-size:12.0pt;\">Atypical mitotic figures</span></li><li><span style=\"font-size:12.0pt;\">Indicates genetic instability \u2192 leads to chemotherapy resistance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other factors:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Older age (&gt;10 years)</span></li><li><span style=\"font-size:12.0pt;\">Large tumor size</span></li><li><span style=\"font-size:12.0pt;\">Tumor rupture before/during surgery</span></li><li><span style=\"font-size:12.0pt;\">Bilateral disease</span></li><li><span style=\"font-size:12.0pt;\">Metastases at diagnosis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Robbins and Cotran pathologic basis of disease 10th edition page: 292</strong></span></p>",
    "correct_choice_id": 54507,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 14995,
    "choices": [
      {
        "id": 59940,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minimal change disease </span></span></p>"
      },
      {
        "id": 59941,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgA nephropathy </span></span></p>"
      },
      {
        "id": 59942,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Membranous glomerulopathy </span></span></p>"
      },
      {
        "id": 59943,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Focal segmental glomerulosclerosis</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the commonest nephropathy seen in a patient with cancer? </span></span></span></p>",
    "unique_key": "Q7923389",
    "question_audio": null,
    "question_video": null,
    "map_id": 32296,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Membranous glomerulopathy </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Membranous Glomerulopathy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is the correct answer as it is the most <strong>common type of nephropathy </strong>associated with <strong>cancer, particularly solid tumors</strong>. It&#39;s characterized by<strong> diffuse thickening of the glomerular basement membrane </strong>due to<strong> subepithelial immune complex deposits</strong>. Patients often present with nephrotic syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Minimal Change Disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Minimal change disease typically presents with<strong> nephrotic syndrome </strong>and is most commonly seen in<strong> children</strong>. It&#39;s characterized by the <strong>loss of foot processes of podocytes visible </strong>under an <strong>electron microscope </strong>but with <strong>normal-appearing glomeruli </strong>under a <strong>light microscope</strong>. It&#39;s <strong>less </strong>commonly associated with<strong> malignancies</strong> compared to <strong>membranous glomerulopathy</strong>, although it has been linked with<strong> Hodgkin disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: IgA Nephropathy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Also known as <strong>Berger&#39;s disease</strong>, IgA nephropathy is marked by <strong>IgA immune complexes </strong>deposited in the <strong>glomerular mesangium</strong>. It&#39;s<strong> not </strong>typically associated with <strong>malignancy </strong>and presents with <strong>hematuria, </strong>and sometimes with <strong>proteinuria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Focal Segmental Glomerulosclerosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: FSGS is characterized by<strong> scarring in segmented regions of the glomeruli. </strong>It can occur as a <strong>primary renal disease </strong>or <strong>secondary to other conditions</strong>, including some<strong> cancers</strong>, but is <strong>not </strong>the most common <strong>cancer-related nephropathy</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Membranous glomerulopathy </strong>is most commonly linked to<strong> malignancies </strong>and presents as <strong>nephrotic syndrome </strong>characterized by <strong>proteinuria, hypoalbuminemia, and edema</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em>&nbsp;</em></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 912) </span></em></strong></span></span></p>",
    "correct_choice_id": 59942,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15004,
    "choices": [
      {
        "id": 59976,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemihypertrophy</span></span></p>"
      },
      {
        "id": 59977,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aniridia </span></span></p>"
      },
      {
        "id": 59978,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertension </span></span></p>"
      },
      {
        "id": 59979,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral polycystic kidney </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wilm&rsquo;s tumor is associated with all of the following except</span></span></span></p>",
    "unique_key": "Q8582599",
    "question_audio": null,
    "question_video": null,
    "map_id": 32297,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Bilateral polycystic kidney </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral polycystic kidney:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bilateral polycystic kidney is <strong>not </strong>typically associated with <strong>Wilm&#39;s tumor. Polycystic kidney disease (PKD) </strong>is a separate<strong> genetic disorder </strong>characterized by the development of<strong> fluid-filled cysts </strong>in the kidneys.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Hemihypertrophy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Wilm&#39;s tumor </strong>is associated with <strong>Beckwith Wiedmann syndrome </strong>which has <strong>hemihypertrophy </strong>as one of the components. Hemihypertrophy is the <strong>asymmetric growth </strong>of one side or part of the body. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Aniridia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Aniridia refers to the <strong>absence of the iris. Wilm&#39;s tumor </strong>is associated with<strong> WAGR syndrome (Wilm&#39;s tumor, Aniridia, Genitourinary anomalies, and mental Retardation).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Hypertension:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Wilm&#39;s tumor </strong>can cause<strong> hypertension due to the secretion of renin </strong>by the tumor cells. This can lead to <strong>renovascular hypertension.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wilm&#39;s tumor</strong>, also known as <strong>nephroblastoma, </strong>is <strong>not </strong>associated with <strong>bilateral polycystic kidney.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 481)</span></span></em></strong></strong></span></span></p>",
    "correct_choice_id": 59979,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15006,
    "choices": [
      {
        "id": 59984,
        "text": "<p><span style=\"font-size:12.0pt;\">Mutant VHL gene</span></p>"
      },
      {
        "id": 59985,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Loss of 3p</span></p>"
      },
      {
        "id": 59986,
        "text": "<p><span style=\"font-size:12.0pt;\">Trisomy 7/17</span></p>"
      },
      {
        "id": 59987,
        "text": "<p><span style=\"font-size:12.0pt;\">Loss of 3q</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The cytogenetics of chromophilic renal cell carcinoma is characterized by:</span></p>",
    "unique_key": "Q1566718",
    "question_audio": null,
    "question_video": null,
    "map_id": 32298,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C) Trisomy 7/17</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Chromophilic renal cell carcinoma is a distinct type of RCC.<strong> Trisomy 7/17:</strong> Trisomy 7/17 is a characteristic <strong>cytogenetic aberration </strong>found in<strong> chromophilic renal cell carcinoma</strong>. It is one of the defining features of this subtype.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A: Mutant VHL gene: </strong>The <strong>VHL gene </strong>is commonly associated with <strong>clear cell renal cell carcinoma (RCC), not chromophilic RCC.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B: Loss of 3p:</strong> <strong>Loss of 3p </strong>is a genetic alteration commonly observed in <strong>clear cell RCC, not chromophilic RCC</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D: Loss of 3q:</strong> Loss of 3q is also associated with<strong> clear cell RCC, not chromophilic RCC.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Chromophilic renal cell carcinoma </strong>is characterized by <strong>specific cytogenetic aberrations</strong>, notably loss of the Y chromosome, trisomy / tetrasomy &nbsp;of<strong> chromosomes 7 and 17,</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 950)</strong></span></p>",
    "correct_choice_id": 59986,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 15007,
    "choices": [
      {
        "id": 59988,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nephrogenic rests </span></span></p>"
      },
      {
        "id": 59989,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monophasic morphology </span></span></p>"
      },
      {
        "id": 59990,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplasia</span></span></p>"
      },
      {
        "id": 59991,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Capsular infiltration </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In Wilm&rsquo;s tumor, the following finding leads to emergence of resistance to chemotherapy:</span></span></span></p>",
    "unique_key": "Q2166661",
    "question_audio": null,
    "question_video": null,
    "map_id": 32299,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Anaplasia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplasia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Anaplasia is a<strong> histological </strong>feature characterized by the <strong>presence of cells with large, hyperchromatic, pleomorphic nuclei and abnormal mitoses. </strong>It correlates with underlying<strong> p53 </strong>mutations and is associated with the emergence of<strong> resistance to chemotherapy.</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>5% </strong>of tumors reveal <strong>anaplasia</strong>, defined as the presence of cells with<strong> large, hyperchromatic, pleomorphic nuclei and abnormal mitoses </strong>and the presence of <strong>anaplasia correlates </strong>with underlying <strong><em>p53 </em>mutations </strong>and the emer&shy;gence of <strong>resistance to chemotherapy. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Nephrogenic rests:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Nephrogenic rests are <strong>precursor lesions </strong>seen in <strong>Wilms tumor</strong>. They are<strong> not </strong>directly associated with <strong>resistance to chemotherapy</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Monophasic morphology:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Monophasic morphology refers to the<strong> histological appearance </strong>of the <strong>tumor</strong>, where it predominantly consists of one type of tissue. While it may <strong>influence tumor behavior, </strong>it is not specifically linked to resistance to chemotherapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Capsular infiltration:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Capsular infiltration refers to the<strong> invasion of the tumor </strong>beyond its<strong> encapsulated boundary</strong>. While it may indicate a<strong> more aggressive tumor behavior, </strong>it is<strong> not </strong>directly linked to<strong> resistance to chemotherapy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anaplasia in Wilms tumor</strong>, characterized by specific <strong>cellular </strong>features and associated <strong>p53 mutations</strong>, leads to the emergence of <strong>resistance to chemotherapy</strong>, <strong>highlighting </strong>the importance of <strong>recognizing </strong>this histological feature for <strong>prognosis and treatment planning</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 481) </span></span></em></strong> </span></span></span></p>",
    "correct_choice_id": 59990,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15016,
    "choices": [
      {
        "id": 60024,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schistosomiasis </span></span></p>"
      },
      {
        "id": 60025,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ascariasis</span></span></p>"
      },
      {
        "id": 60026,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malaria</span></span></p>"
      },
      {
        "id": 60027,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Any of the above </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transitional cell carcinoma bladder is associated with which of the following?</span></span></span></p>",
    "unique_key": "Q3722182",
    "question_audio": null,
    "question_video": null,
    "map_id": 32293,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Schistosomiasis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schistosomiasis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Schistosomiasis, </strong>particularly infection with <strong>Schistosoma haematobium, </strong>is well-established as a <strong>risk factor </strong>for the development of <strong>bladder cancer</strong>, especially in<strong> endemic areas </strong>such as<strong> Egypt and Sudan</strong>. The <strong>eggs </strong>of the parasite are <strong>laid in the bladder wall</strong>, causing <strong>chronic inflammation </strong>which can lead to<strong> mucosal squamous metaplasia, dysplasia, and potentially neoplasia</strong>, often resulting in<strong> squamous cell carcinoma</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B (Ascariasis):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Ascariasis is an infection caused by <strong>Ascaris lumbricoides</strong>, an <strong>intestinal roundworm</strong>. It is <strong>not </strong>typically associated with the development of<strong> bladder cancer</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C (Malaria):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Malaria is caused by<strong> Plasmodium parasites. </strong>It affects <strong>red blood cells and the liver</strong>, but it is<strong> not </strong>associated with the development of <strong>bladder cancer</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Schistosoma haematobium infection </strong>is a significant <strong>risk factor </strong>for <strong>bladder cancer </strong>in <strong>endemic areas</strong>, leading to <strong>chronic inflammation </strong>and an<strong> increased risk of squamous metaplasia, dysplasia, and carcinoma</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 960)</span></em></strong></span></span></p>",
    "correct_choice_id": 60024,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15017,
    "choices": [
      {
        "id": 60028,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">p53 </span></span></p>"
      },
      {
        "id": 60029,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">p16 </span></span></p>"
      },
      {
        "id": 60030,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">p7 </span></span></p>"
      },
      {
        "id": 60031,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KRAS </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gene associated with superficial papillary urothelial neoplasm?</span></span></span></p>",
    "unique_key": "Q2095891",
    "question_audio": null,
    "question_video": null,
    "map_id": 32294,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) p16 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(p16):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The p16 gene, also known as<strong> CDKN2A</strong>, encodes for the <strong>cyclin-dependent kinase inhibitor p16/INK4a</strong>, which is a <strong>tumor suppressor</strong> that regulates the <strong>cell cycle</strong>. <strong>Deletions</strong> affecting the <strong>9p21 region </strong>where <strong>CDKN2A </strong>is located are common in <strong>superficial noninvasive papillary tumors </strong>of the bladder, making<strong> p16 a gene </strong>associated with these<strong> tumors</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Particularly common </strong>(occurring in <strong>30% to 60% </strong>of tumors) are losses of genetic material on <strong>chromosome 9 </strong>(including monosomy or <strong>deletions of 9p and 9q</strong>). These abnormalities are often the only chromosomal changes present in <strong>superficial noninvasive papillary tumors. </strong>The <strong>9p deletions </strong>(9p20) affects tumor<strong> suppressor gene CDKN2A, </strong>which encodes the <strong>cyclin-dependent kinase </strong>inhibitor <strong>p16/INK4a and ARF</strong>, a protein that augments<strong> p53 function</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A (p53):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>p53 gene </strong>is a well-known<strong> tumor suppressor gene </strong>that is often<strong> mutated </strong>in a variety of cancers, leading to <strong>loss of cell cycle control </strong>and <strong>enabling the formation of tumors</strong>. While<strong> p53 </strong>mutations are common in many cancers, they are <strong>not </strong>the most commonly associated <strong>gene </strong>with<strong> superficial papillary urothelial neoplasms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C (p7):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is <strong>no </strong>well-characterized <strong>tumor suppressor gene </strong>known as <strong>p7 </strong>in the context of <strong>superficial papillary urothelial neoplasms</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D (KRAS):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> KRAS gene </strong>is an <strong>oncogene </strong>that can lead to<strong> cancer </strong>when<strong> mutated, </strong>as it encodes a <strong>protein </strong>that is involved in <strong>cell signaling pathways </strong>that control<strong> cell growth</strong>. While <strong>KRAS mutations </strong>can be present in <strong>many cancers</strong>, they are<strong> not </strong>the most commonly associated <strong>mutation </strong>with<strong> superficial papillary urothelial neoplasms</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Losses of genetic material </strong>on<strong> chromosome 9</strong>, including deletions of<strong> 9p21 </strong>that affect the<strong> CDKN2A gene </strong>encoding <strong>p16/INK4a, </strong>are often the only <strong>chromosomal changes </strong>present in </span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">superficial papillary urothelial neoplasm</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> </strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 958)</span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"> </span></span></span></span></p>",
    "correct_choice_id": 60029,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15018,
    "choices": [
      {
        "id": 60032,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pleomorphic </span></span></span></p>"
      },
      {
        "id": 60033,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Embryonal </span></span></p>"
      },
      {
        "id": 60034,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alveolar </span></span></p>"
      },
      {
        "id": 60035,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Botryoid</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common type of rhabdomyosarcoma is?</span></span></span></p>",
    "unique_key": "Q7874661",
    "question_audio": null,
    "question_video": null,
    "map_id": 32295,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Embryonal </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B (Embryonal):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Embryonal rhabdomyosarcoma </strong>is the most common type of<strong> rhabdomyosarcoma</strong>, particularly in <strong>infancy and childhood</strong>. This <strong>subtype </strong>often presents as a <strong>grapelike mass</strong>, especially when occurring in<strong> hollow organs like </strong>the <strong>vagina or urinary bladder</strong>, referred to as<strong> sarcoma botryoides</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A (Pleomorphic):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Pleomorphic rhabdomyosarcoma </strong>is a <strong>type of rhabdomyosarcoma </strong>that typically occurs in <strong>adults </strong>and is characterized by a <strong>wide variety of cell shapes and sizes</strong>. It is not the most common type of rhabdomyosarcoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C (Alveolar):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alveolar rhabdomyosarcoma </strong>is<strong> less common </strong>than the <strong>embryonal subtype </strong>and has a <strong>distinctive histological appearance resembling pulmonary alveoli</strong>. It typically occurs in older children and teenagers.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D (Botryoid):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Botryoid rhabdomyosarcoma </strong>is a variant of the <strong>embryonal type </strong>that manifests as a <strong>polypoid, grapelike mass. </strong>While it is a <strong>recognized subtype</strong>, it is<strong> not </strong>the most common form of <strong>rhabdomyosarcoma overall</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">MC&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">sarcoma in <strong>infancy </strong>or childhood is <strong><em>embryonal rhabdomyosarcoma</em></strong>. In some cases, it manifests as a polypoid grapelike mass (sarcoma botryoides). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">MC&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">sarcoma in the bladder in <strong>adults </strong>is <strong>leiomyosarcoma.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 962)</span></span></em></strong></strong></span></span></span></p>",
    "correct_choice_id": 60033,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15009,
    "choices": [
      {
        "id": 59996,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common in adult </span></span></span></p>"
      },
      {
        "id": 59997,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with deletion of chromosome 11p13 </span></span></span></p>"
      },
      {
        "id": 59998,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with MIC-2 genes </span></span></span></p>"
      },
      {
        "id": 59999,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Commonest presentation is hematuria</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">True statement regarding Wilms tumour is:</span></span></span></p>",
    "unique_key": "Q4966232",
    "question_audio": null,
    "question_video": null,
    "map_id": 32288,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Associated with deletion of chromosome 11p13 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with deletion of chromosome 11p13:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutations in the <strong>WT1 gene</strong>, located on <strong>chromosome 11p13, </strong>are commonly associated with <strong>Wilms tumor</strong>. Therefore, option B is <strong>correct</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Common in adult:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Wilms tumor (nephroblastoma) </strong>primarily occurs in <strong>children</strong>, typically between the <strong>ages of 2 and 5 years old</strong>. It is <strong>very rare in adults</strong>, so <strong>option A is incorrect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Associated with MIC-2 genes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> MIC-2 gene is <strong>not specifically </strong>associated with <strong>Wilms tumor</strong>; instead, it is related to<strong> Ewing sarcoma</strong>. Therefore,<strong> option C is incorrect</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Commonest presentation is hematuria:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> most common </strong>presentation of Wilms tumor is an <strong>abdominal mass</strong>, <strong>not hematuria</strong>. Therefore,<strong> option D is incorrect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wilms tumor </strong>is primarily a <strong>childhood kidney tumor</strong>, commonly associated with<strong> mutations in the WT1 gene located on chromosome 11p13</strong>, highlighting the genetic basis of this malignancy and aiding in its<strong> diagnosis and management.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 481) </span></span></em></strong> </span></span></span></em></strong></p>",
    "correct_choice_id": 59997,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15010,
    "choices": [
      {
        "id": 60000,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Invades renal vein </span></span></p>"
      },
      {
        "id": 60001,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hematuria may occur </span></span></p>"
      },
      {
        "id": 60002,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arises from proximal convoluted tubule </span></span></p>"
      },
      {
        "id": 60003,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More common in females </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are true about renal cell cancer except: </span></span></span></p>",
    "unique_key": "Q6118789",
    "question_audio": null,
    "question_video": null,
    "map_id": 32289,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) More common in females&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Renal cell carcinoma </strong>has a higher incidence in <strong>males compared to females</strong>. The <strong>male-to-female ratio </strong>is approximately<strong> 2:1</strong>. This <strong>gender predilection </strong>is observed across<strong> various age groups.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Renal cell carcinoma (RCC) </strong>is known for its<strong> propensity to invade nearby structures</strong>. The <strong>renal vein </strong>is commonly involved, and extension into the <strong>renal vein </strong>is not uncommon in advanced cases. This<strong> invasion </strong>can potentially <strong>lead to the spread of cancer cells </strong>to <strong>other parts of the body</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Hematuria </strong>is a common symptom of <strong>renal cell carcinoma. </strong>As the <strong>tumor grows</strong>, it can invade<strong> blood vessels </strong>within the <strong>kidney</strong>, leading to<strong> bleeding </strong>which is then <strong>excreted </strong>in the<strong> urine</strong>. However, it&#39;s important to note that <strong>not all cases of RCC present </strong>with <strong>hematuria, </strong>and other symptoms such as<strong> flank pain or a palpable mass may </strong>also be<strong> observed.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>RCC </strong>typically arises from the<strong> proximal convoluted tubule </strong>of the nephron. The exact cell type involved is a<strong> clear cell carcinoma</strong>, which accounts for the <strong>majority of RCC cases</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective :</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Renal cell carcinoma </strong>has a <strong>higher </strong>incidence in <strong>males </strong>compared to females</span></span> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 950) </span></em></strong></span></span></p>",
    "correct_choice_id": 60003,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15011,
    "choices": [
      {
        "id": 60004,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lung carcinoma </span></span></p>"
      },
      {
        "id": 60005,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal cell carcinoma </span></span></p>"
      },
      {
        "id": 60006,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial carcinoma </span></span></p>"
      },
      {
        "id": 60007,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatocellular carcinoma </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">VHL syndrome is associated most commonly with which carcinoma:</span></span></span></p>",
    "unique_key": "Q3046716",
    "question_audio": null,
    "question_video": null,
    "map_id": 32290,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Renal cell carcinoma </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>primary tumors </strong>associated with<strong> VHL syndrome </strong>are <strong>renal cell carcinoma (RCC), hemangioblastomas </strong>of the <strong>central nervous system, and pheochromocytomas</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Lung carcinoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>VHL </strong>syndrome is<strong> not </strong>classically associated with<strong> lung carcinoma. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Endometrial carcinoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>VHL syndrome </strong>is<strong> not </strong>known for an <strong>increased risk of endometrial carcinoma. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Hepatocellular carcinoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>VHL </strong>syndrome is <strong>not </strong>typically associated with <strong>hepatocellular carcinoma</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>VHL syndrome </strong>increases the risk of certain tumors, particularly <strong>renal cell carcinoma</strong>, <strong>hemangioblastomas, and pheochromocytomas. </strong>A secondary objective is to discern the types of carcinomas not typically associated with VHL syndrome. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 949) </span></span></em></strong> </span></span></span></em></strong></p>",
    "correct_choice_id": 60005,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15012,
    "choices": [
      {
        "id": 60008,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal cell cancer </span></span></p>"
      },
      {
        "id": 60009,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wilms tumor </span></span></p>"
      },
      {
        "id": 60010,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma lung</span></span></p>"
      },
      {
        "id": 60011,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatocellular carcinoma </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudohermaphroditism is seen with which of the following tumor?</span></span></span></p>",
    "unique_key": "Q1855999",
    "question_audio": null,
    "question_video": null,
    "map_id": 32291,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Wilms tumor</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Wilms tumor):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Wilms tumor, or <strong>nephroblastoma, </strong>is a<strong> childhood kidney cancer</strong>. <strong>Denys-Drash syndrome </strong>is a <strong>rare disorder </strong>associated with <strong>Wilms tumor </strong>and is characterized by<strong> gonadal dysgenesis, </strong>which can present as <strong>male pseudohermaphroditism, </strong>and <strong>nephropathy </strong>often leading to<strong> renal failure</strong>. Abnormalities in the <strong>WT1 </strong>gene are a <strong>hallmark </strong>of this syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Denys-Drash syndrome </span></em></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is characterized by <strong>gonadal dysgenesis (male pseudohermaphroditism) </strong>and early-onset <strong>nephropathy leading to renal failure</strong>. The characteristic <strong>glomerular lesion </strong>in these patients is <strong>diffuse mesangial sclerosis</strong>. These patients also demonstrate <strong>germline abnormalities in <em>WT1. </em></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In addition to <strong>Wilms tumors</strong>, these individuals are also at<strong> increased risk </strong>for developing <strong>germ cell tumors </strong>called <strong>gonadoblastomas, </strong>almost certainly a <strong>consequence of disruption </strong>in <strong>normal gonadal development</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A (Renal cell cancer):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Renal cell cancer is<strong> not </strong>typically associated with <strong>pseudohermaphroditism, </strong>which is a condition where an individual has <strong>reproductive organs or secondary sex characteristics of both sexes</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C (Carcinoma lung):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lung carcinoma is a <strong>malignant lung tumor </strong>characterized by <strong>uncontrolled cell growth in tissues of the lung. </strong>This condition is not related to pseudohermaphroditism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D (Hepatocellular carcinoma): </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatocellular carcinoma is the <strong>most common </strong>type of<strong> primary liver cancer</strong>. It has <strong>no direct </strong>association with<strong> pseudohermaphroditism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Denys-Drash syndrome, </strong>which is associated with <strong>Wilms tumor</strong>, can present with <strong>male pseudohermaphroditism </strong>due to mutations in the<strong> WT1 gene</strong>, and this can lead to <strong>disorders of sexual development. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 481)</span></span></em></strong></p>",
    "correct_choice_id": 60009,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 14999,
    "choices": [
      {
        "id": 59956,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">On cut section yellowish nodules are seen</span></span></p>"
      },
      {
        "id": 59957,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with tuberculosis</span></span></p>"
      },
      {
        "id": 59958,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Foam cells are seen </span></span></p>"
      },
      {
        "id": 59959,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giant cells are seen </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following about xanthogranulomatous pyelonephritis are true except: </span></span></span></p>",
    "unique_key": "Q6556121",
    "question_audio": null,
    "question_video": null,
    "map_id": 32302,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Associated with tuberculosis </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>XGP </strong>is<strong> not </strong>associated with <strong>tuberculosis</strong>. <strong>Tuberculosis </strong>of the<strong> kidney </strong>typically presents with<strong> caseating granulomas </strong>and <strong>acid-fast bacilli </strong>can often be identified with <strong>special staining</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xanthogranulomatous pyelonephritis (XGP) </strong>is<strong> not </strong>typically associated with <strong>tuberculosis. </strong>It is more commonly associated with <strong>chronic bacterial infections (</strong></span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">associated with <em>E. coli, Proteus mirabilis, Pseu&shy;domonas, Streptococcus faecalis</em> and<em> Klebsiella</em>). </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Escherichia coli </strong>is often the <strong>causative organism</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Yellowish nodules </strong>on the cut section are characteristic of<strong> XGP</strong>. These nodules are composed of <strong>lipid-laden macrophages </strong>known as<strong> foam cells </strong>and are indicative of the<strong> chronic inflammatory nature of the disease.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Foam cells </strong>are indeed seen in<strong> XGP </strong>and represent <strong>macrophages </strong>that have <strong>phagocytized lipids</strong>. The presence of <strong>foam cells </strong>can help in the histological diagnosis of<strong> XGP</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Giant cells </strong>are also a feature of <strong>XGP </strong>and are part of the <strong>granulomatous reaction</strong>. They can be formed by the <strong>fusion of macrophages </strong>and are another indication of a<strong> chronic inflammatory process.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>XGP </strong>is characterized by <strong>yellowish nodules, foam cells, and giant cells, </strong>and is a result of<strong> chronic bacterial infections </strong>rather than <strong>tuberculosis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> / 930)</span></span></em></strong> </span></span></span></p>",
    "correct_choice_id": 59957,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15002,
    "choices": [
      {
        "id": 59968,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell disease </span></span></p>"
      },
      {
        "id": 59969,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberculous pyelonephritis </span></span></p>"
      },
      {
        "id": 59970,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetes mellitus </span></span></p>"
      },
      {
        "id": 59971,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Analgesic nephropathy </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Necrotizing papillitis may be seen in all of the following conditions except:</span></span></span></p>",
    "unique_key": "Q4274304",
    "question_audio": null,
    "question_video": null,
    "map_id": 32303,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Tuberculous pyelonephritis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberculous pyelonephritis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>tuberculosis </strong>can affect the<strong> kidneys</strong>, it<strong> does not </strong>typically cause <strong>papillary necrosis</strong>. Instead,<strong> TB </strong>usually causes <strong>caseating granulomas in the renal cortex.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Sickle cell disease:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Can lead to <strong>papillary necrosis due to vaso-occlusion</strong>, resulting in <strong>ischemia of the renal papillae</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Diabetes mellitus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is a common cause of <strong>papillary necrosis</strong>, mainly due to the effects of<strong> vascular disease and high glucose levels </strong>on the<strong> renal papillae</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Analgesic nephropathy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Chronic use </strong>of analgesics, especially <strong>nonsteroidal anti-inflammatory drugs (NSAIDs), </strong>can lead to <strong>papillary necrosis, </strong>possibly <strong>due to impairment of renal blood flow and interstitial nephritis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture4.jpg\" style=\"height:523px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Causes of papillary necrosis </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetes mellitus </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell disease </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic alcoholism </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vascular disease </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Analgesic abuse nephropathy </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 930) </span></em></strong></span></span></p>",
    "correct_choice_id": 59969,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15003,
    "choices": [
      {
        "id": 59972,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute pyelonephritis </span></span></p>"
      },
      {
        "id": 59973,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic pyelonephritis </span></span></p>"
      },
      {
        "id": 59974,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystitis</span></span></p>"
      },
      {
        "id": 59975,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fanconi syndrome </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28 year young female Katrina present to your OPD with complaints of suprapubic pain, urinary frequency and dysuria. She also passed blood in last voided urine about 30 minutes ago. Her urinanalysis demonstrate the presence of pyuria but no white cell casts. On physical examination, she has suprapubic tenderness on palpation. Which of the following is the likely diagnosis in this patient?</span></span></p>",
    "unique_key": "Q4882370",
    "question_audio": null,
    "question_video": null,
    "map_id": 32304,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Cystitis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystitis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterized by symptoms of <strong>lower urinary tract infection</strong>, including <strong>suprapubic pain, dysuria, urinary frequency, and urgency</strong>.<strong> Pyuria and hematuria </strong>are common findings in <strong>cystitis</strong>, but <strong>white cell casts </strong>are typically<strong> absent.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of the patient in the stem of the question is of cystitis, which is characterized by<strong> pyuria and hematuria </strong>but <strong>absence of white cell casts in the urine</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Acute pyelonephritis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Typically presents with<strong> fever, flank pain, and systemic symptoms </strong>along with <strong>pyuria, leukocytosis, and white cell casts in the urine</strong>. <strong>Suprapubic pain and dysuria </strong>are<strong> less common </strong>in <strong>acute pyelonephritis compared </strong>to cystitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Chronic pyelonephritis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Usually develops as a result of<strong> recurrent acute pyelonephritis </strong>or <strong>chronic urinary tract obstruction. </strong>It may present with <strong>nonspecific </strong>symptoms such as <strong>fatigue, malaise, and flank pain</strong>, but <strong>suprapubic tenderness and dysuria are less </strong>characteristic.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Fanconi syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is a rare <strong>renal tubular disorder </strong>characterized by defects in<strong> proximal tubular function </strong>leading to <strong>renal wasting of electrolytes</strong>, <strong>amino acids, glucose, and low molecular weight proteins</strong>. It typically presents with<strong> metabolic acidosis</strong>, <strong>hypokalemia, hypophosphatemia, glycosuria, and aminoaciduria, </strong>but<strong> not </strong>with symptoms of <strong>urinary tract infection</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> clinical features and diagnostic </strong>findings associated with<strong> cystitis, are lower urinary tract symptoms, pyuria, and hematuria</strong>, but <strong>absence of white cell casts in the urine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 928) </span></span></em></strong> </span></span></span></span></p>",
    "correct_choice_id": 59974,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 15013,
    "choices": [
      {
        "id": 60012,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xanthogranulomatous pyelonephritis </span></span></span></p>"
      },
      {
        "id": 60013,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malacoplakia </span></span></p>"
      },
      {
        "id": 60014,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nail patella syndrome </span></span></span></p>"
      },
      {
        "id": 60015,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tubercular cystitis </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Michaelis Gutmann bodies are seen in:</span></span></span></p>",
    "unique_key": "Q3390978",
    "question_audio": null,
    "question_video": null,
    "map_id": 32300,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Malacoplakia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture5.jpg\" style=\"height:291px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Xanthogranulomatous pyelonephritis </strong>involves the destruction of <strong>renal parenchyma </strong>and the presence of <strong>lipid-laden macrophages (xanthoma cells), </strong>but it is<strong> not </strong>associated with <strong>Michaelis-Gutmann bodies</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Nail patella syndrome: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nail-patella syndrome is a<strong> genetic disorder </strong>characterized by <strong>abnormalities of the nails, patellae, elbows, and iliac horns</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Tubercular cystitis: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tubercular cystitis is associated with <strong>granulomatous inflammation </strong>due to<strong> Mycobacterium tuberculosis </strong>infection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Michaelis-Gutmann bodies </strong>are<strong> intracellular basophilic </strong>structures found in the <strong>cytoplasm of histiocytes </strong>due to deposition of<strong> iron and calcium seen in malakoplakia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 956) </span></em></strong></span></span></p>",
    "correct_choice_id": 60013,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 15014,
    "choices": [
      {
        "id": 60016,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperplasia </span></span></p>"
      },
      {
        "id": 60017,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertrophy </span></span></p>"
      },
      {
        "id": 60018,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atrophy </span></span></p>"
      },
      {
        "id": 60019,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysplasia </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic urethral obstruction due to benign prostatic hyperplasia can lead to the following change in kidney parenchyma:</span></span></span></p>",
    "unique_key": "Q9175902",
    "question_audio": null,
    "question_video": null,
    "map_id": 32301,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Atrophy </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Atrophy):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Atrophy is the<strong> decrease in size of an organ or tissue </strong>due to a <strong>decrease in cell size and number</strong>. <strong>Chronic urethral obstruction </strong>can lead to <strong>hydronephrosis</strong>, which is characterized by the<strong> dilatation of the renal pelvis and calyces </strong>with <strong>progressive atrophy of the kidney </strong>because of the<strong> obstruction of urine outflow</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A (Hyperplasia):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hyperplasia is an <strong>increase in the number of cells in an organ or tissue, </strong>which may lead to an<strong> increase in size of the organ or tissue. </strong>Hyperplasia is <strong>not </strong>typically a result of <strong>chronic urethral obstruction </strong>due to <strong>benign prostatic hyperplasia (BPH).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B (Hypertrophy):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hypertrophy refers to an<strong> increase in the size of cells</strong>, which leads to an <strong>increase in the size of the organ</strong>. While<strong> hypertrophy </strong>can occur in some <strong>cases of obstruction, </strong>in the context of <strong>chronic urethral obstruction due to BPH</strong>, it is <strong>not the primary </strong>change seen in <strong>kidney parenchyma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D (Dysplasia):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Dysplasia is an <strong>abnormal growth or development of an organ or tissue</strong>, which includes changes in <strong>size, shape, and organization of cells</strong>. It is<strong> not </strong>a direct consequence of <strong>chronic urethral obstruction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chronic obstruction</strong>, such as that caused by<strong> benign prostatic hyperplasia</strong>, can lead to the <strong>progressive atrophy of the kidney </strong>due to the<strong> back pressure and subsequent hydronephrosis. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 951) </span></span></em></strong> </span></span></span></p>",
    "correct_choice_id": 60018,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "InvestigationBased"
    ]
  }
];
        let quizName = 'Renal System';
        const quizFilename = 'renal-system-fe4409db.html';
        let hierarchy = ["Cerebellum", "qBank", "Pathology"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>